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Abstract 
 
         Patient empowerment and involvement has become increasingly important 
within the health sector. There has been a lot of focus on patient 
information, and a document like the Patient Information Leaflet 
(henceforth PIL) has been the subject of an ongoing discussion for the last 
ten years and more. The PIL has often been criticised for its lack of user-
friendliness in spite of legal requirements as those outlined  by the 
European Commission Directives. There have, however, been several 
initiatives to improve their readability, comprehensibility and functionality. 
In the UK, the Medicines and Healthcare Products Regulatory Agency 
(MHRA), introduced the ‘Always Read the Leaflet Guideline’, the ‘PIL of 
the month’ issue, and recently, in July 2012, the ‘Best Practice Guidance on 
Patient Information Leaflets’. The aim of the guidelines is to support 
Pharmaceutical companies and medical experts to enhance the layout, the 
language and style of PILs and make them ‘easy to read, understand, and 
act upon’. Considered as a genre with potentially seven moves, in this study 
60 PILs have been manually analysed based upon a systemic functional 
linguistic (SFL) framework to evaluate their quality from the levels of the 
genre, the discourse semantics, and lexico-grammar. The notion of generic 
structure potential is also elaborated according to frame theory. 
Furthermore the visual features of layout and design have been examined in 
accordance with the EU requirements and with the MHRA’s recommended 
guidelines. 
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FOREWORD 
The present study initially arose from my general interest in health 
information and communication for the lay audience. At first my 
research was dedicated to the popularization of science texts, then to 
written information that promotes patient education, and finally, to 
patient information leaflets (PILs). I embarked on the study of PILs two 
years ago after reading an article which reported about the changes to 
wordings on patient medicine labels because they were found to be 
“confusing and misleading” (Raynor, 2011). Labels are the adhesive 
instructions added to medicinal packets and bottles by pharmacists in 
the UK when dispensing a medicine. They give a very brief summary 
of what the doctor has prescribed for his/her patient. The PIL, on the 
other hand, is a thin folded piece of paper of different sizes, printed in a 
small font, and  found inside the medicine package.  
During the initial part of my research I had the opportunity to 
contact and receive some important information from Professor Theo 
Raynor, a researcher at Luto Research Ltd Company, University of 
Leeds, about patient medicinal written information. He told me to make 
a clear distinction between ‘labels’ and ‘PILs’ because the former are 
produced by  pharmacists, whereas, the latter are issued by 
Pharmaceutical manufacturers.   
I started my research by browsing websites and writing to 
Pharmaceutical companies for sources. Surprisingly, I found that  quite 
a lot had been written about patient information leaflets accompanying 
medicinal containers. Of note, a lot of work had been carried out in: 
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Australia, the U.S.A,  the Netherlands,  Germany,  South Africa,  Iran,  
Palestine,  Hungary, Italy,  and of course, the UK which is one of the 
foremost promoters of health education, empowerment and 
involvement. Involvement means that the person who receives a 
medicine  needs to become an active reader and participant of the act 
of taking a medicine. This aspect of medicine information through a 
popularised comprehensive text, the PIL, motivated me to take on a 
study of patient information leaflets and labels issued in the U.K. in the 
last five/six years. 
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INTRODUCTION 
 
People expect and are entitled to good quality information about their 
medicines, whether prescribed (P) or bought-over-the counter (OTC). 
Informed decision-making by patients and the public about medicines is 
keenly promoted by the British Department of Health (DH), and is an issue 
with which healthcare professionals are increasingly becoming familiar.  
We live in a society rich in health information sources, and consumers 
expect to be able to access information in order to make informed 
decisions about their health and medicines. For many people, the primary 
or only source of information about their medication is the statutory patient 
information leaflet (PIL) which, since January1999, has had to be supplied 
with every medicine packet or bottle. Unlike other sources of health 
information, PILs are highly regulated on a European level to guarantee a 
comprehensible document that contains the essential information to enable 
patients to use medicines safely and gain the most benefit from it. Being 
set out in European and national legislation PILs must comply with 
regulatory requirements (the European Commission Directives and 
Guidelines, 1998, 2001, 2004, 2009). Despite the rules and regulations, the 
UK Medicines and Healthcare products Regulatory Agency (MHRA) 
acknowledges that PIL consumers often do not read their leaflet, because 
they perceive it to be too long or complex (Raynor et al, 2007:2). The 
complexity of PIL production is not only linked to the legal requirements, 
it is also exacerbated by the knowledge asymmetry between the sender, a 
medical expert, and the receiver, a layperson. The receiver side of the 
communication process is very complex for PILs as the potential receiver 
Introduction 
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group consists of a large heterogeneous group, who, in the reception 
situation, might feel anxious, stressed or insecure (Albin 1998: 118). Even 
though text producers might be aware that their potential receiver is a lay 
person, the receiver of many types of medications can potentially be the 
entire population, which means that the text producer can never really have 
a specific receiver in mind, and visualization of the receiver can be 
extremely problematic for the text producer (Askehave and Zethsen 2003: 
26). 
Furthermore, research into mass communication concludes that mass 
communicators use specific cognitive tools to visualize a receiver, and  
studies from other disciplines such as communication and psychology 
show that experts, because of  their expert status, are often unaware of 
what poses problems for lay people, and therefore, might overestimate the 
knowledge of their receivers (e.g. de Jong and Lentz 2007; Lentz and de 
Jong 2009; Hinds 1999; Nickerson 1999 cited in Askehave and Zethsen 
2003: 26). This approach might prove very detrimental to user-
friendliness, and may create within the patient an unhappy feeling caused 
by the amount of information he or she receives about a medication 
(Harrison and Harwood 2004).  
Literature reviews also show that there are a number of readability 
formulas which have been used to assess the structural elements of  PILs 
which  are designed to measure reading difficulties. Formulas, such as 
FOG, Flesch and SMOG, for example, produce a score or number that 
indicates how readable a piece of text is, focusing on the premise that long 
words and/or sentences make text harder. But there are objections to these 
‘readability’ procedures because they are found to be limited. In a paper, 
Dixon-Woods (2001) for example, argues that the focus on readability 
arises from conceptions of the purposes of leaflets as well as from 
Introduction 
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assumptions about the process of communication itself. The dominant 
conception derives from a biomedical perspective: PILs are a means of 
patient education and their purpose is to save time and energy and to 
provide medico-legal security for providers of health care. In this view, the 
PIL is aimed at effecting cognitive, attitudinal or behavioural changes in 
patients, who are irrational, passive, forgetful and incompetent. Readability 
formulas do not take this aspect in consideration, actually they:  
 “ exclude the voice of patients from the evaluation of printed 
information, since the value of leaflets can be predicted by a 
formula about the relationship between syllables and sentence 
length”.   
Dixon-Woods (2001: 1426) 
 
By contrast, conceiving of the purpose of PILs as patient 
empowerment values patients’ rationality, competence, resourcefulness 
and reflexivity. If communication is to be effective, the PIL must be 
‘noticed, read, understood, believed and remembered’ (ibid.).
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OUTLINE OF THE THESIS 
 
The present research project is structured as follows: 
 
Chapter One opens with a literary review on background information 
about health communication and literacy. The sections that follow focus on  
the PIL as regards to its definition, background and rationale. Then  an 
overview of the international and national regulating organizations, that 
control and provide guidelines for the enhancement of patient leaflets to 
meet patients’ needs, are presented. The legal framework (Directives of the 
European Community), actually recommends a standard layout (template) 
which is addressed to all the EU Member States. The following paragraphs 
of Chapter One, and the rest of this study, concentrate on PILs issued in the 
UK only. These are highly regulated by criteria standards as regards to 
language, content and layout. The MHRA, responsible for promoting and 
ensuring best health information and communication, has issued various 
guidelines and initiatives to enhance the quality of British patient leaflets. 
Initiatives such as, PIL user-testing, the ‘PIL of the month’ for best-
practice, and the X-PIL Service for alternative formats for visually or audio 
impaired users, and/or for people whom English is not their first language, 
are amongst those issues which are investigated in these paragraphs. The 
final section is dedicated to the legal classification of medicines in the UK 
to indicate the differences between leaflets that accompany medicines 
dispensed only with a prescription (POM), and leaflets accompanying 
medications that can be supplied without a doctor’s prescription over-the-
counter (OTC) .  
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The second Chapter is dedicated to readability processes and to the 
reading comprehension of PILs. First, a literature review is given as regards 
to readability mental processes and cognitive factors that are involved when 
performing the act of reading a text. Then, an overview of readability 
formulas are mentioned as tools used for assessing readability in general, 
and in particular for assessing PILs. Flesch, Fry  and SMOG formulas, 
mentioned beforehand, are amongst some of the formulas which have been 
applied to measure the readability and comprehensibility of PILs. Research, 
however, consider the drawbacks of these formulas (Lunzer and 
Gardner,1979;  Anderson and Davison, 1988;  Halliday, 1998; Dixon-
Woods, 2001), and demonstrates that  there are parameters which go 
beyond text lexis and sentence length which involve other factors  such as  
prior knowledge, abilities, preferences, strategies and effective factors. The 
closing sections of this chapter focus on the concept of word difficulty, 
sentence length, and the supportive role of prior knowledge. 
 
Chapter Three and Four are devoted to the analysis of the corpus of this 
research and provide results and discussion. Sixty original PILs are 
introduced, and analysed in line with Halliday’s Systemic Functional 
Linguistics (SFL). The method of investigation is manual of the corpus and 
the reason for preferring this procedure to a computerised analysis is that it 
proves to be carrying a more individualistic character. SFLs views 
language as a social semiotic resource people use to accomplish their 
purpose by expressing meanings in context. Patient information leaflets are 
an important adjunct to verbal exchange between doctor/expert and 
patient/lay reader. The value of PILs is dependent upon whether they 
contain useful information and are easily understood. Thus, SFLs has  
provided me with the possibility to study the corpus within  a narrower and 
Outline of thesis 
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wider context of research. Being the PIL, quite a standard genre (as resulted 
from the findings) a computerised study would have been limited to few 
variables. Furthermore, a corpus-based approach is more appropriate for a 
bigger size corpus, and/or for a diachronic analyses. 
Following Halliday’s approach, the PILs selected have been analysed 
within a framework that considers both lexico-grammatical features of 
language and the discourse-semantics. The overall aim of this study was to 
assess the quality of current PILs, and find whether they are patient-
centered, rather than medical/expert-orientated. The theory applied was a 
useful and fruitful tool for exploring a full range of relevant textual 
elements within the corpus in order to identify the writer-reader objectives. 
Frame theory (Paltridge, 1997), for what concerns the notion of generic 
structure potential, has also been used to identify how the structural 
elements of the generic structure of PILs operate.  
 
Referring to the above considerations, my research questions are as 
follows: 
 ●  How stabilized are the text patterns in the corpus, or better, how 
conventional is the text structure? 
● What are the features in a text-based analysis of patient 
information leaflets to contribute to the fulfillment of writer and 
reader objectives? 
●    Is ‘patient centeredness’ manifested  linguistically and how is it 
manifested? 
 
Within the SFL theory, a series of sub-questions have been selected to 
assess the quality of PILs in a more detailed manner. The evaluation has 
considered items which include the overall organizational or generic 
Outline of thesis 
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structure of the text; the rhetorical elements; the meta-discourse; the clarity 
of the role relationship between writer and reader; the headings; the lexical 
density (carried out on section two of the PILs); and specialization of lexis. 
Finally, although the format is not of linguistic nature but essential for 
comprehension, the visual aspect of PILs has also been examined. All the 
design features have been analysed (e.g. general typography, the length, 
illustrations, format and layout), in accordance with legal design guidelines 
(European Commission and MHRA), and based upon research literature 
(e.g. Hartley, 1994; Schriver, 1997; Dowse and Ehlers, 1998, 2005; Piwek 
et al, 2006).  
 
Chapter Four is totally concentrated on the presentation and discussion 
of the results. Following a step by step method, a wide range of examples, 
scanned and copied from the original PILs, are presented, and respond to 
the sub-questions applied within the linguistic framework for assessing the 
quality of PILs. 
 
The fifth and last Chapter of this project, is dedicated to the new 
wordings on medicine labels which had remained the same since 1985 in 
the British National Formulary (BNF), the authoritative textbook that 
medical experts use for looking up information about medicines. In March 
2011, the BNF introduced some important changes following the group of  
Luto’s researchers. The Chapter starts with an overview of the information 
found on the medicine’s dispensing label, continues with the presentation 
of the recent wordings and its rationale, and ends with an interesting 
interview which has been trans-scripted by myself. A reporter of BBC 
Radio 4, interviews Professor Theo Raynor about the changing situation of 
labels in Britain. 
Outline of thesis 
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Finally, there is a list of anagrams used in the thesis, the references and 
an Appendix Section. In Appendix 1, examples of authentic labels are 
shown with the names of some patients who have given me the permission 
to use them for my thesis. Appendix 2 includes all the copies of the corpus 
studied. The PILs  attached are copies of the original leaflets examined, 
where colour, spacing, section separation, features of the headings, sub-
headings, and the date of the PILs can be noticed. All the PILs were 
scanned and saved beforehand, and then copied. However, their dimension 
has been modified in order to fit the pages appropriately, furthermore some 
of the parts have not been copied for space reasons in the thesis. The 
original copies in their complete version may be viewed in the CD that has 
been enclosed, or downloaded in their updated versions in the electronic 
medicine compendium (see 3.4).    
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CHAPTER ONE 
 
PATIENT INFORMATION LEAFLETS (PILs) 
       “Everyone needs written medicines information at some time”.  
(Raynor et al; 2007: 1) 
 
1.1  Overview of Chapter 
This chapter will attempt to explain how health communication has 
developed in the last decades to inform users about health matters, and the 
importance  of health literacy. The following paragraphs are concerned 
with the presentation of the patient information leaflet:  its background and  
rationale; the  main regulating responsible agencies which control PILs; the 
standard layout of a PIL; the rules and regulations within the European 
Community; the patient medicinal leaflet in the UK; what user-testing is; 
the PIL of the Month initiative; other formats of PILs. Finally, the 
classification of medicines in the UK and the difference between P 
medicines and OTC medicines and their relevant package PILs. 
 
1.2.  Health communication and literacy  
Health communication has developed over the last thirty years as a 
vibrant and important field of study concerned with the powerful roles 
performed by humans and mediated communication in health care delivery 
and health promotion. Health information is the most important resource in 
health care and  promotion because it is essential in guiding strategic health 
behaviours, treatments and decisions (Kreps, 1988). 
Chapter 1: Patient information leaflets (PILs) 
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Health communication examines many different levels and channels of 
communication in a wide range of social contexts. The primary levels 
analysis include: intrapersonal, interpersonal, group, organizational, and 
societal communication. Intrapersonal health communication inquiry 
examines the internal mental and psychological processes that influence 
health care, such as health beliefs, attitudes, and values that predispose 
health care behaviours and decisions. Intrapersonal health communication 
inquiry examines the relational  influences on health outcomes, focusing on 
the provider/consumer relationship, dyadic provision of health education 
and therapeutic interaction, and the exchange of relevant information in 
health care  interviews. Group health communication inquiry examines the 
role communication performs in the interdependent coordination of 
members of collectives, such as health care teams, support groups, ethics 
committees, and families, as these group members share relevant health 
information for making important health care decisions. Organizational 
health communication inquiry  examines the use of communication to 
coordinate interdependent groups, mobilize different specialists, and share 
relevant health information within complex health care delivery systems to 
enable effective multidisciplinary provision of health care and prevention 
of relevant risks. Jackson and Duffy (1998) stated that societal health 
communication examines the generation, dissemination, and utilization of 
relevant health information communicated via diverse media to a broad 
range of professional and lay audience to promote health education, health 
promotion, and enlightened health care practice.  
Health literacy comes in very importantly for the comprehension of the 
health material supplied. Health literacy is a concept in health research that 
goes beyond general literacy, which defines the reading ability of the 
individual, because it integrates comprehension and incorporation of health 
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material into use. Healthy People 2010 cited in Ngoh (2009: 47), defines 
health literacy as “the degree to which individuals have the capacity to 
obtain, process, and understand basic health information and services 
needed to make appropriate health decisions”. Boswell et al., (2004) argue 
that  a person’s functional health literacy may be significantly poorer than 
his or general literacy and that health literacy  is: “the ability to read, 
understand and act on health information” (Boswell et al., 2004: 62). 
The increased focus on the importance of health communication, 
especially with the general public, shows that the demand for patient 
information and involvement comes from both the patient and the societal 
push to involve patients in their own health. This is the why UK 
government policy is to provide patients with health information that is 
accessible and of high quality as: 
“quality information empowers people to make choices that are 
right for them”  
(Department of Health. The information standard and 
accreditation, 2010) 
 
Patient information leaflets (PILs) as a medium of communication, play 
a crucial role in patient empowerment and involvement (Holmstorm & 
Roing, 2010) and are considered the most important source of information 
about a medication for the patient (Bjerrum & Foyed, 2003: 58). The leaflet 
must not replace a full discussion between a doctor and a patient but it is 
actually thought of as a consistent basis of information which doctor or 
patient may wish to expand upon. 
 
1.3   What is a PIL? 
A PIL, short for ‘patient information leaflet’, is a document enclosed 
in the sales package of a medicinal product and is written in the national 
language(s) of the country where it is sold. Other names may be found, for 
Chapter 1: Patient information leaflets (PILs) 
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example: ‘consumer medicine information’, ‘instruction leaflet’, ‘package 
insert’, ‘consumer insert’. 
PILs are issued by pharmaceutical companies and have to meet the 
requirements of the medicine regulatory agencies in the country where the 
PIL will be issued. For the European Community countries, these leaflets 
are tightly regulated both by the European Medicine Agency (EMEA) and, 
by the country’s own medicine regulatory agency (see paragraph 7). 
PILs are summarised and simplified versions of  summaries of product 
characteristics (SPCs). The Summary of Product Characteristics is a 
specific document required within the European Commission before any 
medicinal product is authorized for marketing. This summary is the 
description of the product both in terms of its properties, chemical 
substances, pharmacological and pharmaceutical use,  and the clinical use 
that can be made of the product. The EU provides guidelines on the use of 
this document for applicants. The Summary must be completed and 
submitted as an application to the EMEA before marketing is authorized. 
Therefore, the document is an intrinsic part of the authorization, and cannot 
be changed following approval. The SPC is not intended to give general 
advice about treatment of a condition but states how the product is to be 
used for a specific treatment. It forms the basis of information for health 
professionals to know how to use the specific product safely and 
effectively. SPCs are produced for the approval and development of 
medicines and are intended for professionals and experts. A PIL, on the 
other hand, is an adapted version, simplified, popularized, and intended for 
the lay audience. 
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1.4  Background and rationale of PILs 
The need for readily available and useful written patient information on 
medicines was highlighted by a retrospective study on evaluation of 
emergency room visits in the United States (Department of Health and 
Human Services, 2000: 4). The study indicated that a large number of visits 
and hospitalization were a result of simple non-adherence to instructions 
related to prescribed medicines. The questions at this point are: Were the 
patients aware of the consequences of not taking their medication as 
prescribed?  Were they supposed to inform the doctor of side-effects or 
medicine interactions experienced? Who was responsible for a negative 
therapeutic outcome? Did the system fail to provide sufficient information 
to enable patients to protect themselves? The Department of Health and 
Human Services stated that the problem to be addressed was that the 
desired therapeutic outcomes were not achieved, or that patients could be 
adversely affected as a result of their ignorance regarding the medicine to 
take (Department of Health and Human Services 2004: 4). 
In a research project carried out by Mary Dixon-Woods (2001) on the 
publications of discourses about the use of patient information leaflets, 
numerous reasons are given for the motivation of using patient information 
leaflets. For example, leaflets are seen as a possible source of advantage to 
health care providers. Proposed benefits include saving time in the 
consultation, and relieving staff  boredom. Leaflets have also been  
proposed as a possible source of medico-legal advantage, as a means of 
achieving cost-benefits in the national Health Services, or as a substitute 
for expensive professional time, (Dixon-Woods, 2001: 1419).  
As in the case of the Department of Health and Human Services, 2004, 
another  powerful motivation for using patient information leaflets derives 
from a discursive construction of patients as irrational, passive, forgetful, 
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and incompetent. These assumptions themselves draw on a body of work in 
cognitive psychology carried out by Phillip Ley and collegues (e.g. Ley, 
1973, 1977, 1988). Again Dixon-Woods (2001: 1423) refers to Hjelm-
Karlsson (1989), who notes: 
“[...].these findings clearly demonstrate that giving oral 
information to patients   in many cases is equivalent to not 
giving information at all”.  
(Dixon Woods, 2001: 1423) 
 
The verbal advice (patients) are given is often forgotten (Ley, 1979), 
and the medical terminology may be confusing (Boyle, 1970, Baker et al., 
1991: 525)  
These considerations characterise patients as being unreliable witnesses 
to their consultation. Patient leaflets are therefore used to compensate for 
patients’ inadequacies and to bring  their knowledge into line with what is 
medically “correct” (Dixon-Wood, 2001). In the words of Savage (1992):  
“It is crucial to back up verbal advice with written material, as 
the average adult   forgets half of what is told within a few 
minutes”.(1992: 24) 
 
In general, people may only retain about 20%  of what they hear, but 
this may increase by 50% if there is additional visual or written input. 
(Kenny et al., 1998) 
Do patient information leaflets effect cognitive, attitudinal, or 
behavioural changes in patients? According to researchers (Ley, 1979; 
Hjelm-Karlsson, 1989, cited in Dixon-Woods, 2001, 1423) they do, and 
their role is to improve compliance,  because non-compliance is the result 
of incompetence. There is the need to consider patients as active 
participants in their care rather than passive recipients.  Health 
professionals must take  account of patients’ views and preferences and 
share decision-making in appropriate ways (ibid.). 
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Hence, PILs have the goals of promoting the health of the population, 
educating about health problems, stimulating and optimising the use of a 
medicine and “ensure safe, effective and appropriate use when the decision 
has been made to take it (Raynor, 2009). In other words, PILs are to meet 
the consumer’s demand for information about their medicine, condition and 
general health matters (Ley and Morris, 1984; Kay and Punchak, 1988) and 
to strengthen the (verbal) information  given during a GP consultation. 
 
1.5  Responsible Agencies  
There are various national or international organizations that regulate 
medical information. In the United States there is the Food and Drug 
Administration  (FDA) which determines the requirements for patient 
package inserts and labels. Other organizations that regulate medical 
information include the European Medicine Agency (EMEA), which from 
1995 to 2004 was known as the European Agency for the Evaluation of 
Medicine Products. It is based in London   and  was set up after more than 
seven years of negotiations among EU governments. It replaced the 
Committee for Proprietary Medicinal Products and the Committee for 
Veterinary Medicinal Products, though both of these were renamed as the 
core scientific advisory committees.  The Japanese Ministry of Health, 
Labour, and Welfare   (MHLW) is responsible for Japan. Other country-
specific agencies, especially in the case of EU (European Countries) 
countries and candidates, plus countries of South America and many in 
Asia and the Far East, rely heavily on the work of these three primary 
regulators. The Therapeutic Goods Administration (TGA) is Australia's 
regulatory authority for therapeutic goods. They carry out a range of 
assessment and monitoring activities to ensure that therapeutic goods 
available in Australia are of an acceptable standard with the aim of 
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ensuring that the Australian community has access, within a reasonable 
time, to therapeutic advances. 
 
The first patient package insert required by the FDA was in 1968, 
mandating that an   inhalation medication was to contain a short warning 
explaining that excessive use could cause breathing difficulties. Then in 
1970 a patient package insert was required for combined oral contraceptive 
pills  which had to contain information for the patient about specific risks 
and benefits about that medicine. In the UK, the first patient information 
leaflets accompanied inhaled medicines and others that required detailed 
instructions for use, by patients self-medicating outside the healthcare 
environment at the end of the sixties and during the early seventies. In 
other European countries, such as Italy, Germany and the Netherlands, 
information leaflets in medicine packets were already used during the 
sixties. 
 
1.6 .  Layout of a PIL 
The contents and structure of PILs has not remained the same in the 
course of time but has undergone many changes, and is still facing changes 
to meet the requirements of the authorities and, most importantly, the 
patient’s needs. At the end of the eighties, the European Commission 
started to standardize patient information. Before that time, the individual 
European countries each had their own laws regarding the documentation 
of patient information.   
The Directive requires that the PIL is drawn up in accordance with the 
Summary of Product Characteristics and that it contains specific 
information in a specific order. 
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Detailed information on the medicines and the leaflet is available in all 
EU/EE languages on the European Medicines Agency website at:   
http://www.ema.europa.eu.  
 
The Directive prescribes the following seven sections within a PIL: 
● Identification of the medicine 
 Name of the product, the active substance and details of the other 
ingredients, the pharmaceutical form, contents within the pack, the 
name and address of the marketing authorization holder and the 
manufacturer and the way in which the medicine works. 
● Therapeutic indications for the product 
The conditions for which the medicine is authorized. 
● Information which patients need to be aware of prior to taking 
the medicine 
Situations when the medicine should not be used, any precautions 
and warnings, interactions with other medicines or foods, special 
patient populations such as pregnant women or nursing mothers, and 
any effects the medicine may have on the patient’s ability to drive. 
● Dosage and usual instructions for use 
How to take or use the medicine, how often the dose should be 
given, how long the course of treatment will last, what to do if a dose 
is missed and, if relevant, the risk of withdrawal effects. 
 Description of side effects 
All effects which may occur under normal use of the product and 
what action the patient should take if any of these occur. 
● How to store the product 
● Date on which the leaflet was prepared 
(Always read the leaflet – getting the best information with every medicine, 14-15). 
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The PIL must be written in the official language of the member state and 
must also be written in clear and understandable terms for the users. 
 
1.7 Rules and regulations in Europe 
Written medicine information for patients was introduced no earlier 
than the late 1970s in Europe, according to Koo (2005). Until the eighties,  
European countries each had their own regulation, and an important step 
forward was taken by Belgium which, as a pioneer introduced a law in 
1984 stating  that package leaflets had to be written in such a way as to be 
legible for adults who had the educational level of compulsory school, 
which was sixteen in Belgium at the time. Following the example of 
Belgium, Europe decided that henceforth medicine packages had to contain 
a comprehensible patient information leaflet. 
In 1992 the then EEC issued Directive 92/27/EEC  to  standardise 
patient information for all EU countries. Article 8 of this Directive 
stipulates that:  
“[…] the package leaflet must be written in clear and 
understandable terms for the patient and be clearly legible in 
the official language or languages of the Member State where 
the medicinal product is placed on the market. This provision 
does not prevent the package leaflet being printed in several 
languages, provided that the same information is given in all 
the languages used” 
  (Directive 92/27/EEC)  
 
The fact that the then twelve member states of the EEC were obliged to 
comply with this directive, created the need for a multilingual glossary in 
the nine languages spoken in the  former EEC at that moment (EN, NL, FR, 
DE, ES, PT, IT, EL, & DA). This was the immediate cause for setting up 
the Multilingual Glossary of Technical and Popular Medical Terms in 
1993, which was completed two years later  in 1995. The multilingual 
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glossary containing, 1,830 technical medical terms and their popular 
equivalents in the nine languages was put on the web at: 
http://users.ugent.be/~rvdstich/eugloss/welcome.html   at the disposal of 
the general public, where it can still be consulted (Vanopstal and Van 
Wiele, 2009).   
As for Directive 92/27/EE, after a phasing-in period, it came into effect 
across the EU in January 1999 (Dickinson, Raynor & Duman, 2001: 148). 
In 2001, this Directive was revised by Directive 2001/83/EEC and in 2004 
by Directive 2004/27/EEC. The Directive describes the conditions for 
which  all PILs brought onto the European market must comply with. 
According to article 59 of Directive 2004/27 EEC, a package leaflet should 
be drawn up in accordance with the Summary of Product (SPC). The 
Economic Commission validated their Council Directive by stating that the 
purpose was to: 
“provide guidance on how to ensure that the information on the 
labeling and package leaflet is accessible to and can be 
understood by those who receive it in order to guarantee safe 
and appropriate efficacy”.  
(Directive 2004/27 EEC) 
 
The characteristics to be included, are as follows: 
(a) identification of the medicinal product 
1. name, strength and pharmaceutical form, and, if appropriate, if it is 
intended for babies, children or adults. The common name shall be 
included where the product contains only one active substance and 
if its name is an invented name; 
2. pharmaco-therapeutic group or type of activity in terms easily 
comprehensible for the patient; 
(b) the therapeutic indications; 
(c) list of information which is necessary before the medicine is taken: 
1. contra-indications; 
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2. appropriate precautions for use; 
3. forms of interaction with other medicines and other forms of    
interaction (e.g. alcohol, tobacco, foodstuffs) which may affect the 
action of the medicine; 
4. special warnings; 
(d) the necessary and usual instructions for proper use, and in 
particular: 
1. the dosage; 
2. the method, and, if necessary, the route of administration; 
3. the frequency of administration, specifying if necessary the 
appropriate time at which the medicinal product may or must be 
administered; and, as appropriate, depending on the nature of the 
product: 
4. the duration of treatment, where it should be limited; 
5. the action to be taken in the case of an overdose (such as 
symptoms emergency procedures); 
6. what to do when one or more doses have not been taken; 
7. indication, if necessary, of the risk of withdrawal effects; 
8. a specific recommendation to consult the doctor or the pharmacist, 
as appropriate, for any clarification on the use of the product; 
(e) a description of the adverse reactions which may occur under 
normal use of the medicine, and. if necessary, the action to be taken 
in such a case; the patients should be expressly asked to 
communicate any adverse reaction which is not mentioned in the 
package leaflet to his doctor of pharmacist; 
(f) a reference to the expiry date on the label, with: 
1. a warning against using the product after that date; 
2. where appropriate, special storage precautions; 
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3. if necessary, a warning concerning certain visible signs of 
decoration; 
4. the full qualitative composition (in active substances and 
excipients) and the quantitative composition in active substances, 
using common names, for each presentation of the medicine; 
5. for each presentation of the product, the pharmaceutical form and 
content in weight, volume or units of dosage; 
6. the name and address of the marketing authorization holder, and, 
where applicable, the name of his appointed representatives in the 
Member States; 
7. the name and address of the manufacturer; 
(g) where the medicine is authorized in accordance with Articles 28 to 
39 under different names in the Member States concerned, a list of 
the names authorized in each Member State; 
(h) the date on which the package leaflet was last revised. 
 (Directive 2004/27/EC of the European Parliament and of the Council 136/48-
136/49). 
 
The Directive, as a legal instrument, binds upon each Member State to 
which it is addressed. However, the national authorities in each Member 
State (such as the Agenzia Italiana del Farmaco -AIFA- in Italy and the 
MHRA in the United Kingdom) are allowed to adapt the Directive into a 
form they consider most suitable for achieving the objectives in their 
country (according to the EU Pharmaceutical Legislation).  
In 1998 the Pharmaceutical Committee of the European Commission 
published: “A Guideline on the Readability of the Label and Package 
Leaflet of Medicinal Products for Human Use (more commonly known 
as “Guideline on readability”) which was especially aimed at the 
readability of PILs and was to supplement the existing Directive 
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92/27/EEC. In this document, requirements with regard to contents, 
structure, design and style of PILs were drawn up. It provides advice to 
marketing authorization holders (MAH) and does not have legal force; the 
definitive legal requirements are those outlined in the Directive and 
national rules of the Member States. However, this guideline should be 
considered as a “harmonized Community position” which will simplify the 
assessment, approval and control of PILs. Marketing authorization holders 
(MAH) and manufacturers of medicines are allowed to take alternative 
approaches regarding the readability of PILs, but they need to justify their 
procedures.  The Guideline on readability consists of the following 
directions (summarized): 
●  The print size and type should be 8 points Didot. 
●  The spaces between lines should measure at least 3 mm. 
●  Words in full capitals/upper case should be avoided. 
● Colours may be used but must be distinguished from the 
background. 
●  Simple punctuation should be used. 
●  Sentences over 20 words or 70 characters should be avoided. 
● The rules concerning bullet point lists should be obeyed. A group 
of bullet points should be introduced with a colon and a single full 
stop should be placed at the end of the group. A list of bullet 
points should begin with the uncommon and specific case and end 
with the common or general case, unless this is inappropriate for 
the product. 
● A minimum number of words should be used in the bullet points 
and never more than one sentence. There should be no more than 
nine items where the bullet points are simple and no more than 
five when they are complex. 
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●  Abbreviations should be avoided. 
● When possible ‘it' should be used for reference to the medicine, 
avoiding repetition. 
● The paper size should be A4/A5 for long leaflets. The paper weight 
should be no less than 40g/m2. 
● (Sub)headings should be made conspicuous (e.g. by colours) and 
also, headings should be numbered. No more than two levels of 
headings should be used. 
● Sentences should be formulated in an active and direct style. 
● Pictograms should only be used when they make the message 
clearer. 
● Red colour print should only be used for very important warnings. 
● Capitals should not be used indiscriminately. 
(European Commission Guideline on the readability of the label and package leaflet of 
medicinal products for human use,  1998: 3, 4, 11, 12). 
 
The report on readability supplements the Directive on some aspects 
very well, but fails to give good advice on other key aspects of PILs. For 
example, “the text must be readily understandable for the patient” is  vague 
and can be interpreted in many different ways. The guideline fails to give 
concrete advice on this aspect. For this reason, several EU countries have 
published additional reports on PILs’ readability, in order to supplement 
the guideline of the European Commission. 
Included in the Guideline on readability, in1998 the European 
Commission designed a model leaflet in which an example PIL had been 
drawn up (Guideline on the readability of the label and package leaflet of 
medicinal products for human use 13-7). Until November 2005, PILs could 
be set up in two ways: either according to the Directive, or according to the 
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example of the model leaflet. The Directive is not very specific about how 
a PIL should be set up because, as mentioned before, the only concrete 
information the Directive gives, is about a PIL’s content and structure. 
Until November 2005, PILs that were not designed according to the model 
leaflet (as recommended by the Directive) had to be tested. 
In 2004, the revision of the European medicinal law, called the Quality 
Review of Documents (QRD) 2001, was rounded off. The date of 
implementation of this review was 1 November 2005. From this date 
onwards, manufacturers and registration holders of medicines that were to 
be registered for the first time or that had changed drastically were obliged 
to have their PIL’s readability tested. The Guideline on readability includes 
information on testing PILs’ readability but again, the report is not very 
specific about what the test should entail and, moreover, the ’16 out of 20' 
norm (16 out of 20 consumers must be able to answer each test question 
correctly) caused much discussion as this norm was considered too light 
(Guideline on the readability of the label and package leaflet of medicinal 
products for human use 1998: 24-6). Therefore, the individual Member 
States, again, set up their own additional reports in which the tests (user-
testing) were set on (see 1.9). 
 
1.8  Patient information in the United Kingdom 
Patient information with medicines has been regulated in the United 
Kingdom since 1977. Although few medicines at that time were supplied 
with leaflets, those leaflets which were produced had to comply with 
certain legal requirements, such as inhaled medicines. As already 
mentioned, in 1992, the European Commission issued Directive 92/27/EEC 
and implemented it into UK legislation in 1994. In 1993, the then 
Medicines Control Agency produced a guidance document that elaborated 
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on the Directive: “Guidance for the pharmaceutical industry on the labeling 
and leaflets regulation,” and this guidance caused the European 
Commission to publish the Guideline on readability. 
In the United Kingdom, the Medicines and Healthcare products Regulatory 
Agency (MHRA) is the government agency which is responsible for 
ensuring that medicines and medicinal devices work, and are acceptably 
safe. The Patient Information Quality Unit is part of the Vigilance and Risk 
Management of Medicines Division. The Unit is responsible for policy and 
regulation of all types of product information and assesses labels and PILs 
provided by the pharmaceutical industry for compliance with the Directive. 
In 2005, the MHRA published guidance on the Guideline on readability: 
“Always Read the Leaflet – getting the best information with every 
medicine”. In this document it was stated that the Guideline on readability 
had had a great impact on the quality of the information in PILs because 
many PILs started to contain a better balance of the risks and benefits of a 
medicine. However, there is much more which could be achieved within 
the current regulatory framework and therefore the Working Group 
redrafted the Guideline on readability. 
The guideline: Always Read the Leaflet – getting the best information 
with every medicine (2005) contains the following adaptations and 
additions to the Directive and the Guideline on readability: 
● Improvement of risk communication: annex 10 of Always read the 
leaflet, gives extensive information on how risk information should 
be communicated. Attention is being paid to: key points as a 
summary at the start of the section, giving information on the 
benefits of taking the medicine, and guidance on presenting 
statistical information (149-65). 
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● Improvement of usability of PILs: annex 6 of Always read the 
leaflet gives extensive information on how the accessibility and 
readability of a PIL can be improved. Attention is being paid to: 
writing style, typeface, design and layout, headings, use of colour 
and use of symbols and pictograms (97-101). Information on these 
aspects is much more extended in the annex, than in the Guideline 
on readability. 
● Attention is being paid to patients with special needs: annex 6 
provides information on people who need PILs in a different format 
(102-111). 
● Improvement of how to undertake user testing: annex 5 and its 
appendix gives extensive information on how user testing should be 
accomplished. Attention is being paid to: the legal basis, reasons for 
user testing, when to undertake tests, implementation and an 
illustration of one way of undertaking a test (89-96). 
●  Lay terms: in annex 8 of Always read the leaflet. The MHRA has 
produced a list of acceptable lay versions of medical terms in the 
package leaflet (123-8).  
 
Furthermore, the MHRA proposes an extra section, a headline section, 
with key information or general information at the beginning of the leaflet, 
especially designed for people that would consider a leaflet too long or 
complex to read. It is the independent variable and can be defined as: 
“summarizing a few key messages for safe and effective use” (MHRA, 
2005). The key information is presented as a short series of bullet points 
and includes the following information: 
●   benefits of the product 
●   maximum dose or duration of treatment 
●   potential side effects or withdrawal reactions 
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●  contraindications 
●   important drug interactions 
●   circumstances in which the drug should be stopped 
●   what to do if the medicine does not work 
●   where to find further information 
●   stimulation for reading the rest of the PIL 
●   latest update of the PIL  
(Always read the leaflet – getting the best information with every medicine, 151). 
 
As for information concerning  the benefits of medicines, the MHRA 
(2005) states that the risks of a treatment should be placed in the context of 
the potential benefits and this could be achieved by including some general 
information on how the medicine works. According to the Directive, a PIL 
already needs to have the section ‘What is your medicine and how does it 
work?’ and according to the MHRA, this section could be complemented 
with the following information: 
- “why it is important to treat the disease and what the likely clinical 
outcome would be if the disease remained untreated? 
- whether the treatment is for short term or chronic use; 
- whether the medicine is being used to treat the underlying disease (i.e. 
curative) or for control of symptoms; 
- if the latter, which symptoms will be controlled and how long will the 
effects last? 
- whether the effects will last after the medication is stopped; 
- where the medicine is used to treat two or more discrete indications, all 
should be succinctly described as above; 
- where to obtain more information on the condition”  
(Always read the leaflet – getting the best information with every medicine, 158). 
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Items which are most relevant to the patient, for example the impact of 
the medicine, should be given prominence by means of using specific font 
sizes or types (This is part of the layout which is developed in Chapter 
Four). 
Information about side effects  follow the  guidelines below: 
● The scientific term of a condition should be placed in brackets after 
the lay term. 
● In case of serious side effects the action that is to be taken by the 
patient must be described. 
● The duration of risk must be stated. 
● A doctor should be consulted if side effects that are not mentioned 
in the section occur. 
● Serious side effects should be mentioned first, then other possible 
side effects grouped by frequency (most frequent first). Body 
System Order Class grouping should only be used when frequencies 
are not known. 
● Verbal descriptors should only be used if accompanied by the 
equivalent statistical information of which only the upper bound 
should be referred to, e.g. use ’fewer than 1 in every 1,000’ rather 
than ‘between 1 in 10,000 and 1 in 1,000.’ 
● If severity of side effects is known, this should be included in the 
PIL. 
●  If a side effect is dose-related, this should be included in the PIL. 
● Providing links/details of further information sources on side effects 
should be considered. 
● Conveying imprecision of point estimates using terms such as 
‘approximately’/’about’/’around’ when referring to estimates for 
major safety issues. 
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(Always read the leaflet – getting the best information with every medicine, 160-64). 
 
1.9  Readability user-testing of PILs 
Readability user-testing is another compulsory intervention concerning  
patient information leaflets which  became a mandatory step in November 
2005 (in the UK in July 2005). Simon Andriesen, the Managing Director of 
MediLingua
1
 based in the Netherlands, refers to the  European Directive 
2004/27/EC which defines that leaflets should be “legible, clear and easy to 
use”, and that the manufacturer has to deliver a readability test report (with 
a positive conclusion) to the authorities (Andriesen,  2007). This means that 
every PIL must be tested  
and pass the test before being approved.  The  idea for user testing derived 
from an Australian initiative (Koo, 2005, Dickinson, Raynor and Duman, 
2001). It has been in act in Australia since 1994 (Sless and Wiseman, 1997, 
Koo 2005). It is a performance based, flexible development tool which 
identifies barriers to people’s ability to understand and use the information 
presented and indicates problem areas which should be rectified. It is 
particularly useful as part of a leaflet development process and aims to 
identify whether or not the information, as presented, conveys the correct 
message to those who read and should understand it. The user testing 
according to Professor David Sless from the Communications Research 
Institute of Australia (1997) is a “performance based” testing and therefore 
                                                 
1MediLingua provides professional medical translation services. It is based in the 
Netherlands and offers  40+ of the world's major languages. The  work concerns both medicines 
and medical devices. Their customers are pharmaceutical companies, CROs, medical publishers, 
national and international medical and regulatory organizations, and manufacturers of medical 
devices, instruments, in-vitro diagnostics and medical software. They  translate regulatory 
dossier information (SPCs, PILs, labeling), general information about medicines, health and 
treatment, clinical trial documents, and instructions for medical devices. Our services also 
include pre-translation source text editing, translatability assessment, international review 
management, translation validation, harmonization of language versions, user-testing (cognitive 
debriefing), readability testing, and back translation and reconciliation. Simon Andriesen can be 
contacted at  simon@medilingua.com. The website is http://www.medilingua.com. 
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differs from the “content based” approach used in the past, where a 
checklist is applied to ensure that the correct information is present. If 
testing reveals barriers to understanding, carefully considered changes to 
the leaflet will be needed to improve it (MHRA, 2005). Readability user- 
testing is used for changing patient information leaflets so that people can 
understand them better; increase public awareness of medicine and prevent 
misuse. According to the understanding of David Sless, the text of a 
medicine information has three main functions – headings for navigation, 
instructions on what to do and explanations to help understand why to do it. 
When issuing a label or package leaflet, the designer must approach the 
writing and the presentation of each of these functional elements as one 
integrated task because readers do not separate content and form (Sless and 
Wiseman, 1997). 
Sless and Wiseman (1997) argue that usability and usability testing is 
too easy to consider the “scientific” nature of this activity as a validating 
principle in itself. However, when looking at the outcome rather than the 
means, usability testing is an expression of respect for others and a social 
desire to be friendly and helpful to others, which explains the often used 
phase “user friendly”. Taking the latter into consideration, usability testing 
can be much more clearly seen as an act of courtesy, involving people who 
will have to use the material in the process of developing and refining that 
respective material, i.e. the package leaflet in this regard. Therefore, user 
testing is legitimated by its social purpose rather than the methods it uses. 
This is done by asking participants questions about the leaflet. 
The EU published a method for testing the readability of the leaflet in 
the ‘Guideline’, however there isn’t a consensus on the test criteria to be 
used, so providers  of  test services have extracted their own test method.  
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The readability test project begins with a preparation phase, during 
which the test of the leaflet is carefully edited and checked; spelling or 
grammatical errors are corrected and sentences are rephrased. This is an 
important step and according to Andriesen (2007), approximately 70% of 
all changes in the leaflet are made during the preparation phase. The leaflet 
must comply with the template, available in 25 European  languages, 
published by the Quality Review of Documents (QRD) group of the 
European Medicines Agency (EMEA).  
For the test, a list of about 15 questions are prepared that cover the most 
important parts of a leaflet (especially safety aspects). The MHRA (2005), 
requests that each question must perform satisfactorily and considers it 
inappropriate for data to be accumulated and for one or more key messages 
not to be found and understood by participants. Hence, each single question 
of the test protocol has to be listed separately for each patient concerning 
legibility, i.e. finding of information, and comprehensibility and  
understanding of the content. Thus, in case one single question is not 
adequately found by 2 out of 20 patients tested, the user test would have 
already failed. There are, however, differences amongst some PILs  for 
example, Schikel (2007), argues that the sort of approach above mentioned, 
does not seem to be helpful or adequate as a general binding rule, 
especially when considering the enormous differences in terms of the 
length and levels of difficulty of different PILs depending on their 
indication and mode of application (e.g. when comparing a package leaflet 
for an analgesic such as aspirin OTC medicine, with an anticoagulant such 
as a powder inhaler to medicate patients suffering from asthma, POM 
medicine).  
The readability guideline requires that a range of different categories of 
people who might possibly use the medicine, are included in the test 
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procedure. In case of testing medicines for rare diseases, the people 
included should preferably have or have had the respective illness. In 
addition, further demands on subjects to be interviewed are detailed as 
follows with regard to the fact that the information which can be used by 
the least able will be beneficial for all users: 
− Particular age groups such as teenagers and the elderly (especially if 
the medicine is particularly relevant to their age group, i.e. the target 
age groups are preferred). 
− New users or people who do not normally use medicines, simply 
members of the general public. 
− People who do not use written documents in their working life. 
− People who find written information difficult (users who have poor 
eyesight or are dyslexic). 
 
In fact, selection of adequate test persons for the user testing is rather 
challenging especially with regard to the target group for the respective 
indication and, even more difficult, in case the medicinal product has 
multiple indications. To find a reasonable balance, it might be helpful to 
select participants according to the patient populations chosen for the 
clinical trials as part of the marketing authoritative application (MHRA, 
2005). 
In a number of cases, the target group of test people is discussed with 
the competent authority, i.e. the EMEA or the reference member state 
(RMS). This is of particular value and necessity in case of medicinal 
products which can be applied by health care professionals only as the 
choice of the population consulted has to be defined and explained in the 
final test report submitted to health authorities.  
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The readability guideline states that:  
“The people who are likely to rely on the package leaflet for a 
particular medicine will depend upon a number of factors and may 
include carers (e.g. parents, partners, friends, as well as nursing 
assistants) rather than patients if the medicine is generally intended 
for administration by someone other than the patient…”               
(Guideline, 2005) 
 
In a test group there is always a young person (around 18-22 years of 
age) and two or three older people (over 60).  
Before starting a test participants are given an explanation of what the 
test entails.  The aim of  the readability test is to assess whether certain 
information can be found and  understood. The testers are told that it is 
unnecessary to learn the text by heart, and that they can refer to it when 
answering the questions, just as they would do at home. The interviewers 
stress the fact that they are testing the leaflet for readability and not 
examining the  tester’s memory or reading skills. If there is something that 
the tester cannot find, or does not immediately understand, then it is likely 
that there is a problem with the text (or layout) of the leaflet (and not with 
the tester). If a single tester gives an incorrect answer,  that does not 
inevitably lead to changes in the leaflet. However, if a number of testers 
have the same problem finding or understanding the information, it is a 
clear indication that there is probably something wrong with the text. A 
readability test consists of at least two test rounds with a test panel of 10 
testers each. In order not to bias the results by training effects of the 
patients participating in user tests, an appropriate time period is ensured 
between the attendance of different user tests. The MHRA (2005) suggests 
that participants should not be used more frequently than once every six 
months. 
Once having fulfilled the inclusion criteria and being selected as a 
participant for a user testing, the patient and the recruiting person (doctor, 
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pharmacist etc.) will normally receive approximately from £20 to 50€ for 
compensation purposes. 
Since data security is an issue, every participant has to sign a 
declaration of confidentiality agreement. However, the participant’s 
personal data are made anonymous as it is done for clinical trials. In 
addition, a fully operational database helps to effectively manage interview 
dates and to keep the usually tight project timelines for user testing. 
A leaflet only passes a test round if for at least 90% of the questions the 
information is located and if in at least 90% of these cases the information 
in understood (Sless and Wiseman, 1997). After the PIL has passed  its user 
test in its original language, it can be translated into any other European 
language without additional testing. In the UK the result of such user 
testing must be submitted to the MHRA. Any other official European 
language is allowed and sufficient, however, most applicants decide to 
perform their user tests in the United Kingdom for the following reasons:  
The United Kingdom has been a pioneer in developing additional 
guidelines and publishing details on the performance of user tests and has 
been rather strict and demanding concerning the necessity of (additional) 
local user testing and the basic need for user testing. 
In the centralised, decentralised and mutual recognition procedure, only 
the English language version of the package leaflet is agreed during the 
scientific assessment of the EMEA and the competent authorities involved 
in the procedure, respectively. The quality of translations into the various 
languages,  however, should be the focus of a thorough review by the 
applicant or marketing authorisation holder (AH) once the package leaflet 
has been properly tested. Consequently, it lends itself to use the English 
version of the package leaflet for  performing user testing. 
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The MHRA requires all marketing authorizations submitted to comply 
with user testing. Hence, not surprisingly a large number of  contract 
research organizations (CROs) offering services for user testing are located 
in the United Kingdom. 
Manufacturers are happy that the Directive requires only one language 
version to be ‘readability-tested’ because of the cost of a single test. 
However, Andriesen ( 2007). Argues that a leaflet that has gloriously 
passed the test in one language may  be poorly translated into any or all of 
the other EU languages.  
Amongst the leading companies which carry out  user testing,  very 
important  in the UK is Luto Research Ltd
2
 which was created as a spin-
off  company of the University of Leeds. The work team led by Professor 
Theo Raynor  and Dr Peter Knapp try to localize potential  
problems people may encounter when reading the leaflet in ‘real life’ and 
improve the consumer’s ability to handle the PIL.  
In conclusion, although there are still aspects to renew in PILs, they are 
improving in quality as a result of new legal obligations on manufacturers 
to test the documents on potential patients. Testing makes sure that the 
presentation of the information enables patients to find and understand key 
messages for safe use of the medicine and thereby enable them to use the 
medicine “safely and effectively” (Raynor, 2005). 
 
 
 
 
 
 
                                                 
2
Luto Research Ltd is a company of the University of Leeds, created in 2004, which works 
with clients to enhance the clarity of information created by its patients. Since its inception, it 
has carried out more than 15,000 individual participant interviews to ensure that patient 
information materials are fit for purpose.  Visit: www.luto.co.uk 
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1.10  The ‘PIL of the month’ 
In 2008 the MHRA in the UK came up with an initiative that consisted 
of putting best-practice
3
 examples of PILs on their website. The initiative 
was and is still called: ‘the PIL of the month’. The MRHA also published 
the quality criteria for assessing the PILs of the month (see website 
references). The quality criteria  includes a wide range of relevant 
parameters (such as font, size, grouping of side-effects, headlines, the use 
of capitals, etc.) which all need to be taken in consideration to constitute 
best practice. 
 
These parameters should have a huge impact on the user-friendliness 
(readability, comprehensibility and functionality) from a linguistic point of 
view, however, there are still doubts regards to user-friendliness of PILs, 
and, as mentioned beforehand, the overall aim of this research is to assess 
the quality of PILs in order to encounter features which may entail a more 
user-friendly approach compared to former PILs. 
A study carried out by Askehave and Zethsen (2010: 103) reports, that 
the assessors of PILs are not linguists but scientists who tend to applaud the 
good layout, and a good graduation of side-effects for example, but do not 
evaluate and appreciate the linguistic aspects such as syntactical issues. The 
MRHA cannot refuse leaflets as long as they comply with the regulations 
concerning content and structure.  Thus, according to Askehave and 
Zethsen (2010) it seems that the overall legislative EU requirement that 
PILs must be easy to read, understand and act upon, does not hold any 
power in practice.  
 
 
 
                                                 
3
Best practice is a method or technique that has consistently shown results superior to those 
achieved with other means, and that is used as a benchmark. 
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1.11 Other formats for PILs 
In November 2005 the X-PIL Service was launched in the UK. The web 
site X-PIL ensures that patient information leaflets supplied with medicines 
are accessible to everyone, including those with sight impairment. It is a 
leading source of reliable and up-to-date information on UK medicines. All 
package leaflets on the web site are supplied and updated regularly by UK 
pharmaceutical companies. They can be viewed in different sizes on the 
screen by clicking on the font size-menu. In addition, the website details a 
single national phone number (free to use and operating day and night) of 
the Royal National Institute of the Blind (RNIB), where the leaflets can 
also be requested in audio, Braille or large prints. This free service is 
supported and promoted by pharmacists and the NHS. It is a venture by the 
Royal National Institute of the Blind (RNIB) and the national Library for 
the Blind and Datapharm Communications.  
Furthermore, recently a new guidance was issued on behalf of the 
MHRA, on 7
th
 July 2012, which stated that it will become compulsory for 
all companies to supply alternative formats for the readers, and that the 
information about the alternative formats must be written inside the PIL. In 
other words:  
“The PIL is the most obvious way for companies to make 
people aware of the availability of  alternative formats of the 
leaflet such as Braille, CD, audio or large print for example. 
Place this prominently in the leaflet in at least 14 point bold 
text”.   
(Point 1.9;  PIL Guidance, 7/12)  
 
 
Possible wordings inside the PIL include:  
"Is this leaflet hard to see or read? Phone 0123 456789 for help"  
"Reading or sight problems? Call 0123 456789 for help"  
"For information in large print, tape, CD or Braille, phone 0123 456789"  
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"Call 0123 456789 for a leaflet in large print, tape, CD or Braille"  
"Hard to read? Call 0123 456789 for help". 
 
The legal provisions require Manufacturer holders (MA holders) to provide 
the statutory information in a format suitable for blind and partially sighted 
medicine users. This can be achieved in a number of ways and what is provided 
will depend on user preference. MA holders should ensure that they are able to 
provide the statutory information in any format which may be requested on 
behalf of the user. The alternative formats as required by the guidance are: 
 
Large print versions of the leaflet to help many people with sight loss, and 
also for some people with learning difficulties. Individuals have different 
preferences, so there should be the facility to print in a range of font sizes 
rather than have only a single option. The usual range of font sizes is 16-24 
using a clear font which is either roman, semi-bold or bold.  
 
CD, MP3 versions of the leaflet can help people with sight loss, those with 
limited command of English who can understand the spoken word better 
than written text and people with reading or learning difficulties.  
 
Braille versions are useful for the approximately 20,000 Braille readers in 
the UK. Separate guidance on the provision of leaflets in Braille is available 
from the European Commission, and the UK will develop its own 
supplementary guidance to help MA holders meet this obligation nationally.  
 
Electronic versions of the leaflet include email and Microsoft Word 
documents which can be sent on data stick, attached to an email or 
downloaded from a website. These can be useful for blind or partially 
sighted people and others who use a computer with text-to-speech or screen 
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magnification software, or other 'access technology' devices. Website 
standards are available to ensure that the format of the material is suitable 
for use with the access technologies referred to above (PIL Guidance 
7/12/2012). 
 
The PIL supplied in alternative format must be identical to the currently 
approved PIL. To avoid confusion, companies may need to have in place 
measures to explain why there may appear to be differences if a PIL has recently 
been updated.  
Medicine users’ individual requirements and preferences differ, so MA 
holders are asked  to have the resources available to prepare PILs in alternative 
formats on demand rather than holding a store in several different formats which 
would become obsolete whenever any change is made to the PIL. Furthermore 
companies must supply the patients with copies of the leaflets requested for their 
medicines in a timely manner so that they have access to the information whilst 
they are taking the medicine.  
Before designing an additional leaflet, website or audiovisual material 
companies should identify whether the desired outcome can be achieved by 
simplifying the existing PIL without loss of information or by providing 
additional information in the PIL that would be of use to patients and carers. 
Companies should also consider the benefits of working with a patient 
organisation to ensure that the proposed materials meet their needs. 
 
In the past, companies had often provided additional patient support 
materials to prescribers to pass on to their patients, this relied on memory and 
availability of materials at the time of consultation, but much was forgotten, (as 
already seen). Information in the PIL  provides an alternative source to help 
overcome forgetting important medicinal information. 
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There is also further material, apart from the PIL to help patients 
administrate their medication. Again the recent PIL Guidance (2012: 24) refers 
to what further material may be provided as follows: 
 
Additional leaflets  which consist  in reference leaflets for children or 
carers of patients. These additional material may be placed in the PIL, 
but must always be non-promotional.  
 
Simplified leaflets are leaflets written in an easier way to  help people 
with literacy learning difficulties or a limited command of English. 
They may also help older children to understand how to use their 
medicine.  
 
Videos are produced to help explain complex instructions such as how 
to take an inhaled medicine or prepare a complex product.  
 
Booklets are also available to provide additional information, such as 
disease awareness material or information targeted at particular groups. 
The guidance says that it is, however, preferable to include the 
information in the PIL because that is more likely to reach the user.  
 
Magazines are issued too to help  support people who use a medicine 
long-term, for example for people who suffer from diabetes.   
 
Help lines are available as well,  which may take the form of recorded 
information or a live advice service, and can also help most people with 
special access needs. Where a helpline is publicized in a PIL, a copy of 
the script or the recorded information should be provided to the MHRA 
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Product Information Unit in advance to ensure that the content 
complies with the legal requirements.  
 
A leaflet in another language may also be requested by people with 
limited command of English. It is an  option which is particularly 
relevant in certain ethnic groups that have a prevalence of a particular  
disease. Patients must obtain a  faithful translation of the English 
version, which does not need to  ‘ verbatim’  but must adequately 
convey the intended messages.  
 
1.12 Classification of medicines in the UK 
One of the responsibilities of the MHRA is to enforce the provisions of 
the Medicine Act 1968 and associated secondary legislation. The law 
regulates the sale, supply and administration of all medicines available in 
the UK. Each medicine is assigned to one of three legal categories: POM, P 
and GSL. The following classifications determine how medicine can be 
supplied to the public (MHRA: Availability, prescribing, selling and 
supplying of medicines, 2 September, 2005). See Tab. 1.1 
 
Prescription 
only medicine 
POM Requires a prescription from 
specified health professional/s 
‘In the 
dispensary’ 
Pharmacy 
medicines 
P Must be sold by, or under the 
supervision of, a registered 
pharmacist 
‘Behind- 
the-counter 
General sales 
list medicine 
GSL Available from any sales 
outlet, e.g. garage, newsagent 
‘Off-the-
shelf’ 
Tab 1.1 Classification of medicines in UK 
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The P category requires supervision by a pharmacist, and might be 
thought of as the ‘behind-the-counter’ category to differentiate it from the 
‘off-the-shelf’ medicine (Fenichel 2004, cited in the Report  prepared by 
the Board of Science of the British Medical Association,  2005)
4
.  The OTC 
market includes the P and GSL categories, and also herbal and 
homeopathic medicines, which are currently not regulated under the same 
system. In the UK, medicines in the P category can only be sold ‘under the 
supervision’ of a pharmacist, from registered pharmacy premises, whereas 
the GSL products can be sold both from pharmacies, without the 
supervision requirement, and from any retail outlet. The pharmacy 
supervision requirement has been interpreted in its strictest sense with a 
requirement for the pharmacist to be both present in the pharmacy and 
aware of all such sales. To some extent this has limited the pharmacist from 
taking on other duties and thus has led to a review of alternative 
arrangements as part of a wider consultation on making the best use of the 
pharmacy workforce (Department of Health 2004). 
 
1.12.1   Use of OTC medication 
Over-the-counter medicines have traditionally been used to treat self-
limiting minor ailments. The scope for treating such conditions has been 
extended by the switch from prescription to OTC status of effective 
treatments.  
Like all treatment interventions, OTC medicines bring both benefits 
and risks. Potential benefits to the public include enabling people to take 
control of their own illnesses and rapid and convenient access to 
treatments. Potential risks include adverse effects and the possible misuse 
                                                 
4
 The Report (2005) concerning OTC medication on behalf of  the BMA (British Medical 
Association), is available at:  www.bma.org.uk 
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of certain medicines. Potential benefits to the healthcare system include 
more efficient use of the doctor capacity through the transfer of 
consultations about minor ailments to pharmacists and nurses, as well as 
increased individual responsibility and empowerment in the context of 
minor ailments. Baker and Shaw (2004) suggested the term ‘Involved 
Patients’ to denote active involvement in treatment choices and self-
management of health. 
It is estimated however that there is as many as 80% of patients with 
chronic daily  headache (CDH) who overuse pain medications (Dowson, et 
al, 2004). Less people are reading the instructions on the OTC package 
leaflet, and researchers report that this may be due to the increased 
confidence in self-treatment, and/or people’s belief that OTC and non-
prescription medicines are safe and without serious side effects.  
In a nurse bulletin issued by the National Prescribing Centre in 1999, some  
important points were stated for Pharmacists to consider when 
recommending an OTC therapy for self-medication: the  mnemonic 
WHAM: 
W   Who is it for? 
W   What are the symptoms? 
H    How long have the symptoms been present? 
A   Action taken so far? 
M   Any other medication? 
 
As for the choice of product to give the patient, the mnemonic EASE 
should be considered: 
E   How effective is the product? 
A  Is it appropriate for this patient? 
S  How safe is it? 
E   Is the product cost-effective?  
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In the past OTC PILs were not regulated like the P PILs, actually 
they were defined as being shorter and carrying less information. But 
being the only source of information of that medicine, the patient was 
and is required to take even more responsibility for using it. 
In recent years, in fact, following the work of the Better Regulation 
of Over-the-Counter Medicines Initiative (BROMI), the Patient 
Information Quality Unit (PIQU) has extended the notification scheme 
for changes to all medicine leaflets regardless of legal category in 
relation to the packaging components for all medicines subject to a 
marketing authorisation (product license). Hence, OTC PILs are 
currently much more similar to the P medicinal leaflets. 
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CHAPTER TWO 
 
READABILITY OF PILs 
  
The reading process is not simply a matter of extracting 
information from the text. Rather, it is one in which the 
reading activates a range of knowledge in the reader's mind 
that...may be refined and extended by the new information 
supplied by the text. 
(H.G. Widdowson 1979: 7) 
 
 
 
2.1  Understanding PILs 
PILs are still regarded to be difficult and hard to understand by many 
people. In a study by D.K Raynor et al (2007) on the quantitative and 
qualitative review of leaflets tested, findings showed that most people do 
not value the written medicines information for the poor quality in terms of 
content and layout. Anna Lewcock, (03-April-2007)wrote an article called: 
Patient info leaflets found lacking, in which she reported that the working 
group actually found that some patients considered PILs as merely serving 
to fulfill legal and regulatory requirement and protect manufacturers from 
medico-legal actions, rather than give any benefit to the consumers 
themselves. The article may be downloaded at:  
http://www.in-pharmatechnologist.com/content/view/print/156811.  
(Site visited on 18/01/2012).  
 
Obviously, as many studies have shown, the ‘same’ message often 
needs to be framed or presented in different ways in order to be 
communicated most effectively and most persuasively to different people. 
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But what are the factors that make patient leaflets difficult? Or more 
generally, what is a hard text? What is a hard word? And when is a 
sentence difficult to understand? Before a literature review is presented to 
answer these questions, it is essential to understand the cognitive process of 
information processing. By so doing the theory about word difficulty, 
sentence length and prior knowledge will be put into a relevant perspective. 
 
2.2  Text processing  
What happens when people read a text? A mental process takes part to 
build up a coherent meaning. Sanders and Gernsbacher (2004) argue that 
text processing is a dynamic process during which the reader constructs a 
cognitive representation of the information in the text. Even though 
readers’ representations are not identical to the information they read, texts 
contain many linguistics signals that guide comprehension. Reading 
involves many cognitive processes. First, you need to be able to identify 
the printed characters as letters and the letters as words. Secondly, you 
need to hold individual words in memory so that you can understand a 
complete sentence and relate it to previous sentences. You also need to be 
able to comprehend the text and integrate new information conveyed in the 
sentence you are currently reading with information acquired from previous 
portions of the text. Hence, reading involves object recognition, immediate 
memory, long-term memory, semantic memory and many other processes.  
Despite the involvement of so many complex cognitive operations, 
reading seems effortless and is usually very accurate. It differs from spoken 
language in several ways. First, reading is visual and spatial whereas 
spoken language is auditory and time-dependent, and while readers can 
speed up, slow down or pause, listeners cannot do this as listening is 
dependent on the speaker (although it is possible in some cases to ask 
Chapter 2: Readability of PILs 
 
47 
 
someone to repeat themselves). Furthermore, reading involves 
understanding word units that are separated by white spaces, but speech is 
continuous and many words are co-articulated. The meaning of the words 
can be augmented in speech through the use of stresses and accents, but 
this is not possible with printed words (except with the use of italics, for 
example, to emphasise certain words). Reading involves concerted 
attention and controlled eye movements and it is usually difficult to do 
something else while reading.  As for the cognitive steps needed to 
transform signs on a piece of paper into letters into a coherent text there is a 
model discussed by Sanders & van Wijk (2002), cited in Dolk  (2009: 11 ), 
who gives a simplified version of a complete model. 
 
The following figure illustrates that model: 
 
 
 
 
Thoughts  Comprehension 
Coding  Decoding 
Execution Text Observation 
Fig. 2.1  Mental process of information processing 
 
The left hand side of this model represents the steps that the writer has 
to go through to produce a text. Whereas, on the right hand side of the 
model, the information processing of the receiver of the information is 
presented. In short, the reader sees a text by sensory activities of the eyes 
(observation), this message is decoded (decoding) and linked to prior 
Writer´s Process 
 
 
 
 
 
 
 
 
Reader´s Process 
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messages and world knowledge (comprehension). The first step is physical, 
and the latter two are conceptual.  
 
2.3   Psychological research in text comprehension 
Reading texts serves a variety of purposes such as getting information 
about the world, performing certain actions, or escaping into fictional 
worlds. Text comprehension researchers agree that highly complex 
cognitive mechanisms underlie the skill of comprehending texts. Text 
comprehension is an instance of cognitive information processing based on 
the interaction between the text structure and the recipient’s cognitive 
structure. It is only successful if the reader is able to convert a sequence of 
sentences into a coherent text, i.e. to identify semantic relations among the 
text ideas and to build a mental representation that shows connectedness 
(Holler & Eckardt, 2005: 2).  The reader is challenged to create a coherent 
story from the individual sentences he/she reads. This is done by inspecting 
linguistic cues to link words and sentences to each other. Connectives, such 
as ‘because’ and ‘but’, and referential links facilitate this process. This 
search for these linguistic cues is referred to as micro process. Hence, this 
process takes place on a textual, literal base. Consecutive parts of the text 
are connected to each other on a local level: this leads to a superficial text 
comprehension. During  this stage of text processing, these signals are 
related to the reader’s knowledge of the world. The reader makes 
inferences at this moment; he/she adds information to the literal 
information from the text. To create an overall coherence, the reader needs 
a macro process to integrate the information from the text with prior 
knowledge and knowledge about texts’ macro (global) structure.  
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When the reader has successfully fulfilled this process, a mental 
representation of the text has been created, and according to Britton, 
Gülgöz & Glynn (1993) a well written text facilitates this process. 
Kintsch and van Dijk (1978 and  Kintsch, 1998) offer an influential 
theoretical framework of text comprehension, the construction-integration  
theory. They assume that the processing of text involves two sets of sub-
processes: a set of discourse processes such as word retrieval and 
grammatical parsing and a set of discourse processes that relate to the 
output of the lower-level processes to the actual linguistic and situational 
context by deactivating contextually inappropriate concepts. The processes 
of the first set are active during the so-called integration phase. 
Construction-integration cycles may be repeated. If successful, this results 
in a coherent multilevel text representation consisting of three levels of 
representation: a) a mental representation of the actual wording of the text, 
the so-called surface structure (this entails actual words and phrases, and is 
stored in the short-term memory); b) a mental representation of the 
explicitly stated semantic information, the so-called text base, 
(understanding the information presented in a text, hence, the propositional 
content of the text is integrated with the reader’s prior knowledge), and c) a 
mental representation of the state of affairs denoted in a text, the so-called 
situation model or scenario (Kintsch, 1998). The situation model 
supplements the surface level with the reader's prior knowledge. Zwaan 
(1999) states that “comprehension is first and foremost the construction of 
a mental representation of what that text is about: a situation model.” The 
mental representations of single events are the building blocks of situation 
models. Readers keep track of at least five situational dimensions during 
comprehension: space, causation, objects, intentionality and time. A 
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situation model is stored in the long- term memory, and can be updated in 
case new information becomes available (Zwaan and Radvansky, 1998).  
 
2.4  Can readability be measured? 
 
Lunzer and Gardner (1979) view reading comprehension as an active 
process, not as a passive process: it involves a triangular relationship 
between reader, author and text, hence, a text must be readable. But  can 
the readability of a text be measured? A well-known way of assessing 
whether a text can be read and understood easily is a readability formula. 
Research into readability began in the 1920s, and an array of metrics have 
been designed since then and have been made use of in different fields. In 
fact, more than a hundred readability formulas have been developed which 
are based on some combination of the number of words per sentence, word 
length and word familiarity. In general, a readability formula is intended as 
a quick and conventional measurement which usually takes into account 
only easily measurable aspects of a text such as word difficulty and average 
sentence length. A weighted combination of these measurements yields a 
number for each text. Some readability formulas produce estimates that 
represent grade levels; others range over a 100 point scale where higher 
numbers indicate greater readability For example, the Fry Readability 
Formula (Fry 1967) applies a simple formula based on the ratio of words of 
three or more syllables in 100 word excerpts from the beginning, middle 
and end sections of a text. A similar approach is taken in SMOG (Simple 
Measure Of Gobbledgegook) and the FOG index. More complex formulae 
are employed in two of the most commonly used measures, the Flesch 
Reading Ease score and the Flesch-Kincaid Reading Grade Level 
(FKRGL). These were designed principally to assess reading texts for 
schools, but are also frequently used for other kinds of text (Fulcher, 2007). 
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The Flesch formula is based on the English language and takes the average 
number of syllables per word and number of words per sentence into 
account. 
In 1996 Ley and Florio provided an informative summary of a number 
of readability tests and reported that there was a high correlation between 
the results obtained in a range of texts using different methods. Their 
general conclusions, as far as readability is concerned, was that ‘much of 
the literature produced for patients, clients and the general public is too 
difficult’(1996: 25).  
In a research work concerning patient information leaflets, Garner et al 
(2011: 9), opine that “these tests have considerable limitations”. At a 
purely practical level, the validity of a readability score requires a 
minimum word count (e.g. 100 words of continuous text), which are in 
excess of those in many PILs, such as those that accompany over-the-
counter medicines. More fundamentally, these tests ignore factors such as 
the nature of the topic, the ordering of ideas, choices of sentence structure 
which do not affect length, and the reader’s background knowledge and 
stylistic and personal expectations. Anderson and Davison (1988:25) point 
out that “scholars of readability are aware of the impossibility of reducing 
all text properties to formula variables” and that the formula values should 
not be taken as “anything but rough predictions of the text ease or 
difficulty” (ibid.:25). Objecting to readability formulas on the grounds that 
reading difficulty may be affected by the purpose and background of the 
reader and the inherent difficulties of the subject matter, Davison and 
Kantor (1982) opine that the popularity of readability formulas is attributed 
in part to the fact that they are generally quick and easy to apply. Most 
contemporary word-processing software packages do, in fact, include a 
readability measure facility which are expressed as a clear numerical value. 
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So while a formula and an index scale may sound like useful tools to 
evaluate a text, a number of actual problems have been identified because 
they take no account of non textual dimensions such as context (prior 
knowledge, purpose for reading), cultural differences (Bruce and Rubin, 
1988), and visual element. Text related factors, such as sentence structure 
and the legibility of print, e.g. the layout, typographical features, and the 
reading conditions (Johnson, 1998: 1)are not taken in consideration. 
Proponents of readability formulas claim to be measuring text difficulty or 
comprehensibility but they do not involve a broader range of parameters 
than those offered by readability formulas only. Contrary to those formulas, 
Bruce and Rubin (1988) argue that: 
“The concept of readability concerns many different factors 
including ‘reader specific factors, such as motivation, interest, 
values, or purposes…” 
 
Thus, they conceive: 
“[…] a readability formula as a method of assigning a 
numerical estimate of readability to a text”.   
(Bruce and Rubin,1988: 8) 
 
Readability is, therefore, a multifaceted concept, and is mainly 
concerned with the problem “of matching between reader and text”  
(Johnson, 1998: 1).  
Role-relationship between author and reader (Halliday, 1996), the 
structure or organization of the text are essential for understanding written 
text used for the development and evaluation of doctor-patient written 
information. Although word difficulty and sentence length look like factors 
that have a negative influence of the readability of a text, their actual 
contribution is a point of discussion according to some scholars like 
Anderson and Davison (1988: 25 ). 
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2.5  Word difficulty 
Long words and long sentences have not been considered to be 
imperative for a hard and unreadable text. So what is a hard word, and 
when are sentences difficult to understand? The subsequent paragraphs will 
elaborate on this matter.  
Word difficulty as referred to in readability formulas is defined as: “the 
percentage of words that do not appear on a list of words familiar to 
children, the length of words in syllables or the length of the words in 
letters” (Anderson and Davison, 1988: 27). This might sound like a solid 
definition to assess the difficulty of a text. However, most long, infrequent 
words are clear derivatives and compounds. Additionally, words that are 
unknown to the reader do not cause comprehension challenges per se. An 
exception is a text that is full of difficult words (Stahl, 2003, Anderson and 
Davison, 1988).  
Words can be conceptually difficult or lexically difficult (Anderson and 
Davison, 1988:28). Lexically difficult words represent a concept that is 
familiar to the reader, but the word itself is not known. The meaning of a 
lexically difficult word can often be retrieved from the text’s context. 
Lexically difficult words may effect text comprehension on a text base 
level. Stahl, et al (1989) conclude in their article ‘Prior knowledge and 
difficult vocabulary in the comprehension of unfamiliar text’ that 
(lexically) difficult words influence recall on three levels: the sequence of 
information, central and supporting information. This micro-process of 
information processing deals with the literal, textual structure of the text 
leading to the text base level.  
Conceptually difficult words, on the other hand, represent a concept 
that is unfamiliar for the reader. This makes it hard to link a correct 
meaning to the word. Conceptually difficult words are often related to a 
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certain scheme. Schemata are mental representations of stereotypical 
situations (Zwaan and Radvansky, 1998). Often these words are (only) 
known to a certain group of people who are considered the experts of a 
certain sector. For example, a financial manager might encounter a 
profound amount of conceptual difficult words in a PIL, whereas a doctor 
might have difficulties reading a publication about a banking business. 
Conceptually difficult words impede the comprehension process on a 
higher level: the readers cannot integrate the new information with his/her 
prior knowledge. Hence, conceptually difficult words have an impact on 
the higher levels of text comprehension, whereas lexically difficult words 
influence the text base level.  
Concrete and abstract words also have an effect on comprehension. For 
concrete words there is a ‘direct sensory referent’ and their mental images 
are easily accessible (Schwanenflugel and Stowe, 1989). Sentences with 
abstract words take longer to read (Schanenflugel and Shoben, 1983). 
Moreover, processing abstract words takes longer than concrete words due 
to a lack of prior knowledge. However, when both are presented in a 
supporting context there is not a lot of difference in processing time 
(Schwanenflugel and Stowe, 1989). Written text has less contextual 
support, therefore, communication is more dependent on words, and 
especially on the precision of word choices. 
When we relate this knowledge to PILs, we can say that they 
potentially entail a relative high amount of conceptually difficult words. 
The question is whether conceptually (and lexically) difficult words can be 
avoided in PILs. Being of medical genre, difficult words are bound to be 
present, however, it is essential not to isolate these words but embed them 
in a comprehensible context. Most likely, formulations like these can be 
found in the sections where ‘Taking X with other medicines’ and ‘possible 
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side effects’ are stated. For example; the (abstract) word ‘beta-blockers ’ 
could mean anything for most laymen. However, if this word is imbedded 
by the following information ‘a type of medication used to treat high blood 
pressure, irregular heart rhythm’, the exact meaning of the word loses its 
importance. The word ‘beta-blockers’ is explained on a lexical and 
conceptual level, which should facilitate text processing, as supported by 
Schwanenfluger and Stowe (1989).  
 
2.6  Sentence length 
Another factor that was used in readability formulas was the length of 
the sentences. Gibson (2000) provides insight in the way  sentences are 
processed. The process of assembling sentence structures is called sentence 
parsing. The two components in this process are: words are connected into 
a structure for the input so far (integration) and the structure as a whole is 
also tracked to integrate incomplete dependencies (storage). Nested and 
multiple nested structures require a lot of resources during the processing. 
This would support the readability formula assumption that singular 
sentences are more easily understood. However, two short sentences are 
not always more easily comprehended than one long sentence. As 
discussed before, connectives can make relationships explicit and this 
facilitates text comprehension. Anderson and Davison (1988: 25) give three 
illustrating sentences: 
1.   I moved the switch. The lights went off.  
2.   I moved the switch, because the lights went off. 
3.   The lights went off because I moved the switch.  
 
Sentences 2 and 3 are longer than 1, but contain a connective to make 
the meaning of the relationship between the clauses explicated. The 
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ambiguity and vagueness of sentence 1 is cleared in 2 and 3; in two 
different ways. Pearson (1954-1975, as cited in Anderson and Davison, 
1988:26) showed that children prefer sentences containing an explicit 
connective and also comprehend those sentences better. This result was 
confirmed by Irvin and Pulver (1984). Thus, connectives facilitate the 
comprehension process even though they increase the lengths of the 
sentence.  
In a PIL, (multiple) nested structures, as explained above, should be 
avoided whereas,  connectives can effectively be used to make clausal 
relationships explicit.  
 
2.7  Prior knowledge for PIL comprehension 
In literature another factor that facilitates the reading process is prior 
knowledge. Prior knowledge plays a supportive role in comprehending a 
written message. Patients’ ability to participate in their care and decision 
making depends largely on their knowledge and literacy skills.  It is  a 
reader’s variable and cannot be measured by means of a readability 
formula. According to studies (e.g. Ngoh 2009; Pander and Lentz, 2009) 
there is a gap between what patients ought to know to use dispensed 
medications appropriately and what they actually know. In a country like 
the UK, the effects of low literacy is especially found in the elderly, non 
completers of Secondary school, immigrants and those who have a lower 
cognitive ability. Cognition is the portion of a person’s comprehension, 
memory, and recall is used to perform tasks that require some knowledge, 
skills, or ability. The implication therefore is that patients must understand 
what they are supposed to do before they can follow medical 
recommendations. Thus, as previously discussed, prior knowledge helps 
the reader/patient to create a situation model, a schemata, and according to 
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their pre-existing schemata, before initiating a therapy, patients should 
know :  
1 what their main problem is; 
2 what they need to do; 
3 why it is important to do that. 
 
The patient leaflet structure needs to follow reader’s schemata and in 
the schema theory, background knowledge serves as a scaffold to help 
encoding information from a text (Stahl et al, 1989). Conventional patterns 
are the basis for the expectations about the coherence relationships between 
the different parts of the texts (Sanders and Spooren, 2010). For the 'taking 
medication' schema the information is grouped in three groups: 
identification of medication, adherence with medication and outcomes 
(Morrow, Leier, Adrassy, Tanke and Stine- Morrow, 1996, cited in 
Walgalter and Vigilante, 2003:340). From the definition stated, we can 
derive that background knowledge facilitates the process of information 
processing.  
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CHAPTER THREE 
 
HALLIDAYAN  LINGUISTICS APPLIED TO PILS 
 
      A PIL for every ill? 
(Kenny et al, 1998) 
 
In the following chapter a manual analysis of a corpus of 60 original 
PILs is conducted based upon a systemic functional linguistics (SFL) 
approach. Michael A. K. Halliday, the ‘father’ of systemic functional 
linguistics, saw the need to have a linguistic system that was more 
sociological in orientation. Since there have been many changes and 
revisions to improve patient information leaflets in order to make them 
more user-friendly for the recipient hence, promoting patient centeredness, 
(thanks to user-testing, for example, see Chapter One), Halliday’s theory 
seemed as most appropriate and adequate for exploring a full range of 
relevant textual elements within PILs. This idea is also consolidated by the 
fact that: 
“SFL is a dynamic system: it keeps changing in step with the 
environment in which it is operating. In this way, it has been 
remarkably stable since its beginning in the 1960s; it has 
remained stable because it has kept changing, thus a meta-
stable system. SFL is also an open system: as it changes, new 
features are added in response to new needs”. 
    (Matthiesen,  2009: 12)  
 
To analyse the main characteristics of PILs in line with Halliday’s 
theory, and assess whether they currently address the consumer in a more 
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user-friendly manner, the following questions are taken in consideration for 
the analysis: 
What are the features in a text-based analysis of patient information 
leaflets, to contribute to the fulfilment of writer and reader objectives? 
How stabilized are the text patterns in the corpus, in other words, how 
conventional is the text structure, considering the corpus analysed? 
Is ‘patient centeredness’ manifested linguistically and how is it manifested? 
Bearing in mind both the discourse-semantic and lexico-grammatical 
level, the following linguistic features are studied: the generic structure of 
the text; the rhetorical elements; the specialization of lexis; the meta-
discourse; the role relationships; the use of headings, and lexical density. 
Although not of linguistic consideration, the visual aspects of PILs is 
considered as well since it is an integrated factor of readability and 
understanding.. 
 
3.1  PILs within the SFL theory 
The framework is based upon the theoretical construct of systemic 
functional linguistics (Halliday, 1994). Systemic theory considers how 
people use language to make meaning and how language is organised to 
enable meaning to be made. According to the theory, language is viewed as 
a pattern of interlocking systems, from the smallest unit (e.g. words or 
phrases) up to the largest (e.g. a paragraph or longer piece of text) 
(Halliday, 1994: 23). In order to approach a text, we need to break it down 
into smaller, more manageable units, for example, into sentences (those 
units of the writing system beginning with a capital letter and ending with a 
full-stop), which in turn can be broken down into clauses, (which combine 
with each other to form a text), which then can be broken down into groups 
of words, and so on. This sort of analysis looks at the units of grammar in a 
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more systematic way to identify the functions of language and foreground 
the role of grammar as a resource for construing meaning (ibid.). 
The interaction between text and context is the means by which the 
reader constructs meaning, so any model of text needs to take context into 
account. The two types of context identified in this analysis are context of 
culture and context of situation (Halliday and Hasan, 1989). (see Table 
3.1.) Context of culture refers to knowledge, beliefs, ideologies worldviews 
and value systems that have an impact upon the language used in a text. 
This shapes the way the text is organized at the macro-level (Martin, 1992), 
that is, the macrostructure of the text. Paltridge (1997) quoting Van Dijk 
(1980), notes that macrostructure refers to the ‘higher level semantics and 
conceptual structure that organise the ‘local’ micro-structures of discourse 
interaction and their cognitive processing” At the highest level within 
context of culture is the genre, which considers the organization or 
structure of the overall text with respect to its specific  purpose (Swales, 
1990). Patient information leaflets in this case, may be regarded as a subset 
of the genre of healthcare materials. The comprehensibility of this 
information will be affected by expectations of what is considered to be a 
conventional text structure for this particular type of genre (Swales, 1990). 
The next context level, context of situation, refers to the non-verbal 
environment in which the text is actually functioning (Halliday and Hasan, 
1989). The key situational aspects impact on the type of language used. 
Three of these can be described as variables of the context of situation 
which have consequences for language: what is being talked about -ﬁeld-, 
who is involved –tenor-, and the channel of communication –mode- whose 
function is accorded to the text and to the rhetorical aim, that is to say, 
“what part the text is playing” , (Halliday 1994: 76). 
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These three variables of context define the register to which the text 
belongs. Register is the: 
“set of meanings, the configuration of semantic patterns, that 
are typically drawn upon   under the specified conditions along 
with the words and structures that are used in the realization of 
these meanings.” 
(Halliday, 1995:248). 
 
There is an inextricable, systematic association between context and 
text (the extra-linguistic situation and the linguistic/verbal realizations) and 
vice versa: the context activates the meanings (i.e. the semantics) that are 
realized in and by the grammar (i.e. lexico-grammar). Hence, a register 
may be defined as a “culturally specific text-type which results from using 
language to accomplish something” (Gerot & Wignell 1994 cited in Freddi, 
2007: 14). To develop a register description of patient information leaflets, 
it is necessary to identify what is most fruitful to examine, hence, the field, 
the tenor and the mode, (see Table 3.1). Texts reflect these key situational 
aspects, in that they deal with experience of the world, express 
interpersonal relations and are ‘knitted together’ so that they can be 
understood. The degree to which a given text is understandable to a reader 
is dependent upon: the nature of the topic that is being communicated;  the 
reader’s expectations; prior knowledge, (as mentioned in the previous 
chapter); and the perceived role relationship between writer and reader. 
Other aspects important for comprehensibility include the organization of 
the text and density of information. To create a patient information leaflet 
as an effective functional text, a writer needs to structure the text in such a 
way that it is appropriate to readers’ needs. Frame theory predicts a certain 
commonality between individuals in the way they approach a particular 
type of text (Paltridge 1997). Thus, for the PIL, the patient frame may be, 
for example, ‘doctor using knowledge to assist patient with information 
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that will guide behaviour and help prevent any adverse events’ (Clerehan & 
Buchbinder 2006: 45).  
The Table below shows the model of systemic functional text 
evaluation for PILs: 
 
Context of culture Context of situation 
Genre 
Register 
Field (What 
is being 
talked about). 
Tenor 
(Who is 
involved). 
Mode 
(Channel of 
communication) 
Schematic structure 
of text: PIL 
Use of 
medicine: 
side effects, 
etc. 
Professional 
relationship: 
expert 
‘informing’ 
lay person. 
Leaflet handed-
out with 
medicine. 
Tab 3.1 Systemic functional text model for PIL evaluation. 
 
3.1.1  Organisation of the text (generic structure) 
The notion of generic structure potential is elaborated by Paltridge, 
(1997), drawing on Hasan (1989), to present how the structural elements of 
a given text operate: what elements can or must occur, where they can/must 
occur, and how often they occur. Different types of text with their 
characteristic overall ‘generic’ structure consists of a series of sections or 
‘moves’. Holmes (1997: 325) defines, a move as: “a segment of text that is 
shaped and constrained by a specific communicative purpose”. 
Each move consists of a number of elements or steps that are combined 
to constitute information in the move, which makes sense for a particular 
audience in a given situation (Hasan, 1989; Swales, 1990; Paltridge, 1997). 
Written patient information about a medicine should provide instructions 
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about the contents, dosage, interaction with other medicines, storage and 
accounts of its potential benefits and side-effects.  
The comprehensibility of a text will be affected by expectations of the 
‘moves’ included, and how these are organised, i.e. their order or sequence. 
For example in PILs logical background information about the medicine 
appears nearer to the beginning of the text than the end, because research 
shows that patients scan the text but wish to have basic information about 
the medicine before going on with the reading, if they continue reading. 
Thus, there are some ‘moves’ which are considered essential and some that 
are considered useful, but not essential. 
 
3.1.2 Function of each ‘move’ in relation to the reader (rhetorical   
elements) 
The function of each ‘move’ in relation to the reader may be to 
define/explain, inform or instruct the reader. These functions are called 
rhetorical elements and their purpose is to influence the reader. For 
example, background information about the medicine in a PIL is apparently 
to inform the reader, whereas, in relation to the medicine dosage, it may be 
more appropriate to instruct the reader. If the relations between the writer 
and reader are not clear from point to point, it may not be obvious to the 
reader what to do with the information that is presented. For example, the 
reader may be informed that the dose of a medicine may need to be 
increased, but who is expected to monitor and vary the dose?  
Hence, at a rhetorical level, there is a procedure for taking the 
medicine; this procedure comprises a goal (taking a tablet) and a method, 
which consists in turn of a sequence of steps. These are all rhetorical 
concepts/moves which are part of the message no matter how it is 
expressed. 
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In PILs, according to layout formats, there are about seven sections and 
‘moves’ accordingly, and they all signify distinct communicative purposes. 
 
3.1.3  Meta-discourse  (Purpose of the text ) 
Meta-discourse is often presented as the writing that we do about our 
writing, rather than about our topic. This brings to a more complex 
understanding of meta-discourse: the linguistic strategies that we use to 
manage the evolving relationship between writer, reader, and text. Hyland 
and Tse point out that:  
“[…] meta-discourse is the range of devices writers use to 
explicitly organize their texts, engage readers, and signal their 
attitudes to both their material and their audience”.        
(Hyland and Tse, 2004:156) 
 
This definition offers a valuable description of what can be 
accomplished through writing choices, and bases the view of writing as a 
social engagement. 
Documents which are designed to support readers in making decisions 
or following procedures make use of ‘meta-discourse’ - language about the 
text itself that explains its purpose and assists the reader’s movement 
around the text (e.g. ‘The main purpose of this leaflet is to...’). These are 
instructive texts which are theme-centered because the text answers a 
number of questions about the act that is to be performed (Pander Maat 
1994). Apart from learning a procedure, which is based on declarative 
knowledge, instructive texts should also contain conceptual information. 
Before users of an instructive text can carry out procedures and 
instructions, they need to know why they are going to carry out certain acts. 
For instructive texts like PILs, this means that procedural and declarative 
information needs to be merged into a recognizable and readable unity. In a 
study about the sequence of information, Ummelen (2005) defines 
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procedural information as text that needs to support the execution of the 
task in a direct manner. It is all the information that instructs users on what 
to do. This information does not only include the action itself, but also the 
condition for an action and the consequences of an action., which can 
concurrently be a condition for a following action. Ummelen (2005: 330) 
calls this sequence an action-centered sequence. The linguistic form in 
which procedural information should be shaped is as follows: 
- action verbs 
- imperative 
- relatively short action steering sentences 
- step-by-step presentation of items 
- direct style 
- if…then constructions. 
Declarative information should contribute to factual knowledge and insight 
(ibid.:331). 
 
Within a readable unity a PIL, should try to answer two questions: is 
this medicine suitable for the patient, and how does he/she use the medicine 
safely and correctly? The single steps are the instructions that are 
communicated to the reader which then need to be followed up. The reader 
wants to know, for example, how often, how much of, and in which way the 
medicine is to be used, The text must convey this sort of information, thus, 
supporting the purpose.  
In updated versions of PILs there should be a clear description of the 
purpose/function of the text because readers should be helped to connect, 
organize, interpret, evaluate and develop attitudes towards that material 
(Kopple 1997 cited in Wang, 2012: 105). 
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3.1.4   Role relationships (author-reader identities and status elations) 
The concept of role relationships is made possible by the fact that in 
any communicative event there should be in principle more than one 
participant, and therefore there must be a role for each of them to play. 
These roles are of two kinds, social roles and interactional roles. The 
former, referred to by Eggins (1994: 63) as Tenor, is dependent on the 
participants’ relatively static social statuses, and it starts from these social 
statuses to predict on the use of certain forms of the language. The latter 
kind of role relationships, on the other hand, is more dynamic since the 
participants can play the different roles interchangeably, and it is often 
through the choices of the language that participants play their roles. This 
kind of role is firmly tied to the immediate interactional, rather than the 
more permanent social, statuses of the participants. An important common 
feature of both kinds, however, is that they are generally more tangible in 
an event of speaking since the participants are typically present and can 
play their roles simultaneously. In written discourse, writers and readers 
also adopt such roles and modify their language accordingly, but the 
interactions are separated from each other and, this is less obvious than 
speaking. 
Halliday (1994) refers to the interactional role relationships as “speech 
roles” and explains what he means by this term as follows: 
“In an act of speaking, the speaker adopts for himself a 
particular speech role, and so doing assigns to the listener a 
complimentary role which he wishes, him to adopt in his turn”.  
(Halliday, 1994:68) 
 
Hence, we use language to interact with other people, to establish and 
maintain relations with them, to influence their behaviour, to express our 
own viewpoint on things in the world, and to elicit or change theirs 
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(Thompson 1996, 2000 cited in Ming, 2007: 78). The interactional role 
relationships can be accounted for both spoken and written discourse ; an 
interrogative, for example, raises the question of who demands the 
information (the questioner) and who is supposed to provide the answer 
(the addressee). It is therefore not surprising to think of the written 
communication as an exchange between the writer and the reader, and to 
explore this structure underlying the written interaction. Although writing 
may be viewed as a “monologic activity, it is nonetheless dialogic in its 
communicative structure” (Nystrand, 1986: 36). Nystrand argues, in fact, 
that the writer makes choices among the options available which are 
determined by his/her reader’s need, not only by the meaning the writer 
wants to convey (ibid.). There is no turn taking or overt exchange, in terms 
of giving and taking, between the writer and the reader, but there is an 
underlying structure that indicates the writer’s awareness of the presence of 
the reader and the modification of the message to accommodate his/her 
needs, reactions and expectations.  
The sort of interaction may be referred to as negotiation of meaning, 
which in broad terms means “the skill of communicating ideas clearly” 
(Bygate, 1987: 27). An important point to be considered, as noted by 
Bygate, is that: 
“[...] it is this aspect of  spoken interaction which contrasts 
most sharply with position of reader and writer in the written 
word”  
(ibid.:28)  
 
The ‘sharp’ contrast about the position of the two participants in the 
written interaction means that there is no direct negotiation between the 
two. Negotiation is in fact an intrinsic feature of any kind of 
communication; what makes it different in written language is that the 
participants are physically not present during the interaction which rules 
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out the possibility of ‘direct’ negotiation. Likewise, Nystrand (1987) 
indicates this difference explaining how negotiation in written discourse, as 
compared to spoken discourse, can be brought about: 
“In talk this negotiation is comparatively conspicuous, 
manifesting itself in turn taking, querulous glances plus 
rephrasing, etc. In writing, however, this negotiation is more 
abstract: the writer must create a text that will effect an 
exchange of meaning in a context of eventual use...”. 
(Nystrand, 1987: 210) 
 
Writers need to take into account different situational variables of the 
context in which their writings will be read, who is going to read them, at 
what time, what their readers want to know and what they do not need to 
know, and so forth. As an example from a formal essay, Nystrand argues 
that a review of literature does not only serve “argumentative purposes” but 
also “communicative function”; it is meant to establish a “communicative 
footing”, i.e. “shared knowledge of common ground with readers” 
(Nystrand, 1987: 203). 
Despite the fact that negotiation underlies all kinds of communication, 
there are clear differences among written genres in how negotiation is 
being carried out. Moving from genres like the formal essay used by 
Nystrand above, to more interactional discourse, we can find instances of 
relatively overt negotiation between writers and readers which are 
sometimes no less explicit than what is normally found in conversational 
exchanges. For example, simple forms of the exchange structure can be 
found in sequences of questions and answers (as shall be seen in the PILs 
examined); the reader’s voice can clearly be heard by means of the writer 
putting words in his/her mouth, and the interaction might be sometimes 
changed according to the reader’s participation; readers and writers do not 
only jointly work out experiential meanings. These aspects of the 
negotiation process are necessary in patient information leaflets. 
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Although most of the linguistic accounts of medical discourse have 
focused on face-to-face communication between doctors and patients (e.g. 
Coulthard & Ashby, 1975; Cicourel, 1985; Tannen & Wallat, 1987; Fisher 
& Croce, 1990; Soyland, 1991, cited in Sultan Al-Sharief, 1996: 9), there 
have been several studies regarding the specific type of written medical 
discourse in medicinal leaflets. 
Medicinal leaflets are in some respects dramatically different from the 
other kinds of medical written discourse. There is no ‘real’ doctor-patient 
communication as in the face-to-face communication, like negotiation and 
dialogue, as discussed before. This is the reason why the text needs to be 
made as explicit as possible and give an authentically interactional 
message, it cannot be just a mere description of the symptoms and 
treatment of the disease. Patient leaflets show concern with the human 
values as with the bare facts. Rather then the writer who “plays 
wholeheartedly the role of dispassionate scientific observer” (Thompson, 
1996 quoted in Sultan Al-Sharief, 1996: 11), in medical leaflets the writer’s 
main task is to interpret the scientific facts in terms of their social and 
psychological effects on the reader/patient. This can be seen in how 
appropriate it is for medical-expert writer to be assertive/directive or 
conciliatory/collaborative in their ‘advice’, and  make it clear to who 
should carry responsibility in the world of action.  
 
3.1.5  The use of headings 
Headings in documents, while related to ‘field’, may be considered as 
instances of macro-themes and thus, related to ‘mode’, following Martin 
(1992). Their role is particularly important in any assessment of 
communicative effectiveness within a functional text. According to Nielson 
(1999), the main heading on the page should provide an overall view of 
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what the text will state in detail. The main function carried out by 
descriptive headings is to be a sort of keyword and allow readers to easily 
identify what each section is about. 
For PILs, the MHRA (see Chapter one, paragraph 7) actually proposed 
the inclusion of a headline section to “ensure that patients are aware of key 
information on the safe and appropriate use of a product” (2005). The 
reason for this being is that some patients do not read their leaflet at all. By 
including the headline section the  MHRA wants to convince the reluctant 
patients to read at least the headline section. Research, in fact, indicates that 
readers using texts to make informed decisions do not usually read through 
the information in a linear way, but ask a series of questions and scan 
through the document to look for answers (Wright, 1999).  
In PILs, however, the inclusion of a headline section, may also be risky 
and this is due to the fact that patients might only read the headline section 
and forget about the rest. This means that they are still not fully aware of 
the risks and benefits of that particular medication. Another issue is 
whether the headline section could have a negative effect on the reader’s 
comprehension and usability of the information. It is quite difficult, 
therefore, to predict what effect the headline section may have on those 
who read it. See example of headlines in Fig. 3.5. 
 
3.1.6  Specialization of lexis 
Specialization of lexis is included under ‘field’ as it is a way of 
encoding “what is going on”, Halliday (1994: 56).  
The connection can also be seen, however, with elements of participant role 
relationships. In other words, lexical choices are made by the writer of a 
medical information document in an expectation of the level of technicality 
required to achieve the communicative objectives. Biber (1988) claims that 
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lexical specificity seems to be correlated with the production of differences 
between speaking and writing. A higher lexical specificity seems to be 
associated to formal written genre, marking a high density of information, 
by reflecting a precise word choice and an exact presentation of 
informational content. The technicality of the vocabulary used in a PIL 
refers to the degree of complexity of the medical terminology and/or other 
vocabulary used. Thus, the writer needs to select and employ words and 
phrases which are understandable to the general public rather than resorting 
to the specialist terminology known from the medical context.  
 
3.1.7  Lexical density 
As already stated in Chapter Two, language is made up of what may be 
called ‘content’ words, with its lexical or conceptual value (e.g. tablets, 
patches, acetate, symptoms, uncoated), and ‘non-content’ words, also 
called ‘empty words’ which have no lexical or conceptual content, they 
only have their grammatical function, (e.g. and, in, whether). The density 
of information in a portion of text or ‘lexical density’ refers to the average 
number of content words per clause. 
According to Halliday (1985), one of the differences between written 
language and spoken language is the density with which information is 
presented. The average lexical density for spoken English is between 1.5 
and 2, and for written English between 3 and 6, “depending on the level of 
formality of the writing” (Halliday, 1985:80). In the PILs selected for this 
study, the lexical density is performed on the second section regarding the 
strength of  the medicine and what it is used for (What X is and what it is 
used for). 
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3.1.8   Visual aspects of the texts 
The visual presentation also needs to be taken into account when 
assessing the quality of texts (Hartley, 1994; Shriver 1997; Paul et al. 
2004). 
In documents, readability, clarity, order, and reliability of information 
are fundamental aspects. The special organization of graphics and text can 
direct reader’s attention and make the interaction more effective. A good 
graphic design creates a visual logic and a positive optical impact. The 
length, format, layout and graphical aspects of the information are all part 
of the visual organization. In the reviewed PIL Guidance of July 2012, the 
MHRA discusses some important information regarding this aspect. It 
discusses that:  
“Before writing the information and setting it out on the page you 
will need to consider where the medicine is going to be used, who 
will be taking it and what particular issues will need to be 
resolved. Involving potential patients at an early stage in the 
drafting of the PIL should ensure success in the testing later on. 
There is scope to consider the needs of older people, those whose 
first language may not be English, people with learning 
difficulties or those with a condition (for example diabetes) which 
may affect their vision”.       (PIL Guidance 07/12 p. 5) 
  
 
Furthermore, using upper-case font sub-heading:  
‘information architecture’, the following is stated about document design 
and development:  
“How the information is set out in the document is an important 
feature of information design. It provides order and structure to 
the document as well as looking at navigation tools within the 
document. Very little information is read from beginning to end 
(with the exception of novels) and the way in which the 
information is arranged is important in ensuring that readers can 
find their way around it. Making the information easy to use is 
an important output from this. 
A well written and clearly designed leaflet can maximise the 
number of people who can use the information to make 
decisions about their medicine so that they can use it safely and 
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effectively. Information design essentially makes complex 
information easy to use and easy to understand. It is a 
particularly important aspect of document development where 
the risk of misunderstanding is likely to come with a cost – 
highly likely in the field of medicines information. This is an 
iterative process and in deciding on a design for a particular PIL 
there are likely to be a number of different designs and 
modifications in the development process”. 
(PIL Guidance 07/12 p. 6) 
Therefore the design and layout of the information is crucial in helping 
patients to find and understand the important messages for safe use within 
the PIL. As stated in Chapter one, leaflets undergo user-testing trials, 
hence, before submitting a leaflet, manufacturers are asked to review the 
way in which the information is set out within the document and to take 
account of best practice to comply with the new article 59 of Council 
Directive 2001/83/EC. Layout is important because it enhances plain text 
by introducing various graphical devices like indented lists, tables, boxes, 
footnotes, along with extra character formatting (italics, bold face, small 
type, etc.). There is not a sharp distinction between ‘plain text’ and ‘text 
with layout’, unless by ‘plain text’ we mean literally a string of words, with 
no punctuation at all. Devices like semi-colons, full stops, and parentheses 
serve as graphical aids as much as bulleted lists or bold face (Bateman et 
al., 2001; Power et al., 2003). 
As required by the PIL Guidance (2012, p.15): 
“manufacturers need to follow a common design and layout, 
firstly because it must be accessible for the reader and 
secondly, because it becomes important that it is easy to re-
enter the text after looking away, in order to retrieve the next 
turn”. 
The Guidance defines the following aspects to consider in the layout: 
 Font style and font size  
 Headings and sub-headings including consistency of placement  
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 PIL dimensions including whether the document is laid out in 
portrait or landscape format and number of columns  
 Use of colour and choice of colour  
 Style of writing and language used  
 Layout of critical safety sections of the PIL  
 Use of pictograms  
 
And, some of the key points that manufacturers must note which help 
patients to navigate the information are: 
1. Headings must be placed consistently and stand out by using 
either a larger font or by emboldening the text; 
2. Judicious use of colour can help but it must not make a contrast; 
3. Patients like an index, so this is very important if a booklet 
format is being used which is known to be more difficult to 
navigate. The reason, presumably, is that an indented list 
represents an exchange of clarity for depth. The crucial points 
can be found more easily, but since space is wasted, there is less 
room for giving additional explanation. Some readers will thank 
the author for easing their task; others will perceive the leaflet as 
an insult to their intelligence. Similar differences are probably 
found between academic fields: while common in scientific 
articles, bulleted lists are rare in humanistic fields like 
philosophy, literary criticism, and history, where the dignity of 
the material seems to demand long paragraphs of continuous 
prose and to preclude anything so vulgar as a list (Bateman et al., 
2001; Power et al., 2003). 
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4. The text size used should be as large as possible and there should 
be a good use of white space. Dense text means patients lose 
concentration and therefore cannot find the information required. 
5. Long lists of side effects are frightening and short bullet points 
have been found to be helpful. The side effects should be 
grouped according to seriousness and allow patients to 
immediately distinguish when to take urgent action. 
6. Related information should be located together and not split over 
different columns or sides of the leaflet. 
7. Information should not be repeated as this is known to confuse. 
8. Information which appears before the index or in a box is 
overlooked by patients so these devices should not be used. 
 
All of the above goes to show that continuous on going work is carried 
out to make PILs more acceptable for the intended audience and the layout 
is one of the fundamental factors because: 
“No matter how well written the text is in the PIL if it is set out 
in a typography which is difficult to read it is unlikely that 
patients will take the time or be encouraged to read it”.   
(PIL Guidance 07/12, p. 5) 
 
3.1.9 The use of pictures 
Many documents, whether they are meant to be seen on paper or on a 
computer screen, contain more than just formatted text. In addition to 
formatting, they may contain such graphical elements as formulas, 
diagrams, and pictures. A considerable amount of research has been done 
on the meaning and use of diagrams, for example: Kerpediev and Roth, 
(2000). My concern in this part of the study is on the use of pictures. 
Pictures are sometimes distinguished from other graphics by the fact that 
they are ‘iconic’: the meaning of a picture arises mainly by its similarity to 
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what it depicts (Hartshorne and Weiss, 1958). Photographs are pictures, 
and so are the more stylised sketches found in PILs. In the following we 
shall see: (a) how pictures contribute to the meaning of a document, (b) 
how they affect the style of the document, and (c) how they can affect the 
wording of the document.  
It is not easy to say in general terms what the meaning of a picture is. 
An interesting exploration of this question can be found in Levesque 
(2003:84), who claims that pictures tend to convey “vivid information: 
information that contains no logical structure beyond predication and 
conjunction”. A picture might say, for example, that a person shook hands 
with another person: it cannot say that they either shook hands or beat each 
other up. The notion of vivid information is an important concept in 
artificial intelligence, and pictures are sometimes seen as a prime example. 
Here, pictures will be viewed as basically expressing existential 
information: A picture of two men shaking hands can be argued to mean 
that at some point in time, two men shook hands in a particular way. 
Photographic’ pictures of this kind convey a wealth of information, and 
would be difficult to generate automatically.  
The picture just discussed, for example, shows in detail how the 
handshake took place. This ‘how’ would be difficult to capture in words or 
mathematical symbols: any symbolic representation would tend to leave 
out something that the picture depicts. This is different with the kinds of 
pictures that are used in instructional texts like PILs where pictures are 
employed to convey ‘discrete’ information of the kind that might also have 
been conveyed by text. Piwek et al, (2006: 13) give an example of the 
illustrated versions of a document followed by the verbal instructions (see 
Fig.3.1 and 3.2): 
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          Fig. 3.1 Illustration of medicine storage    Fig. 3.2 Extracting of  tablet from the blister  
 
To take a tablet, you should first remove it from the foil and then swallow it with water. 
Your doctor will tell you the dosage. Follow his advice and do not change it. If you are 
unsure of your dosage or when to take it, you should ask your doctor. If you take an 
overdose, you should inform your doctor immediately or go straight to your hospital's 
emergency ward. Store the medicine out of the reach of children. 
 
 
The picture shows someone storing away the medicine. The person is 
shown as a woman with longish hair; the cabinet has a specific size and a 
medicinal cross on each of its doors. Little of this has anything to do with 
the meaning of the picture in its current setting. In other respects, the 
picture is rather poor in information. For example, it does not show what 
the woman is doing; there is no medicine in sight! Clearly, the picture 
denotes both more and less than what is depicted: it denotes a person 
(whose gender and appearance are irrelevant) storing away a medicine in a 
place where children cannot reach it. This is the kind of information that is 
conveniently represented using a representation language that allows us to 
represent atomic propositions (involving one or more arguments), 
existential quantification, and conjunction. 
In other words: ‘There is a person x and a medicine y such that x stores 
away y away from children.’ Something similar is true for the other picture, 
which shows how to obtain the tablet (Fig. 3.2). There is a person x and a 
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tablet y such that x removes y from the foil by pushing a finger to the back 
of y.’ (Piwek et al, 2006: 14). 
Even though pictures and text can express similar kinds of information, 
they do not have the same strengths and weaknesses. One strong point of 
pictures, for example, is the immediacy with which they tend to be 
understood (Pineda, 2000). Certain aspects stand out with much more 
clarity and immediacy than others: headers, for example, have a high 
perceptual salience, and the same is true for pictures. A related strength of 
pictures is that they are language-independent, making them especially 
suitable for conveying information to linguistic minorities. 
Another strong point of pictures, relating to their iconicity is their 
suitability for indicating information relating to the relative locations of 
objects. Consider the first of the two pictures above, for example. It can be 
expressed textually, but to express everything that the picture conveys 
would tend to be cumbersome:  
Take your tablet by removing it from the foil by pressing your 
finger against the back of the tablet… 
(Piwek et al, 2006: 14) 
 
An informal study of leaflets in the Association of the British 
Pharmaceutical Industry (APBI 1997 cited in Piwek et al, 2006: 16) has 
shown that pictures are used in about 60% of the leaflets, and that they are 
used heavily to depict:  
 complex pieces of equipment (anti-asthmatic inhalers, inoculators, 
etc.) whose spatial layout of the document is important for the patient 
to understand.  
 actions, such as the steps that need to be taken to clean an inhaler. 
Often, entire sequences of actions are depicted.  
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 continuous quantities – e.g., when creams and ointments are used, 
one frequently sees depictions of the required quantity, sometimes 
positioned on a finger or juxtaposed to a coin to show the relative 
size of the blob.  
 parts of the human anatomy e.g., eye drops, inhalers, thermal 
patches. 
 
There are several examples of pictograms and illustrations in the corpus 
of study which are presented in the Results (e.g. Figures 4.6; 4.7; 4.8). 
 
3.2  Sub-questions for the evaluation of PILs within the SFL  
 framework 
To assess the corpus of the PILs within the SFL framework, the 
following sub-questions have been applied: 
 
1) Overall organizational or generic structure of text:  
What identifiable sections of text or ‘moves’ are present ? 
Are all the essential moves included? 
What is the sequence of moves and is it appropriate? 
 
2) Rhetorical elements: 
What is the function of each move in relation to the reader? 
Are these functions clearly defined and appropriate? 
Is there clear guidance about what to do with the presented information? 
 
3) Meta-discourse: 
Is there a clear description of the purpose/function of the text? 
Are the objectives of the PILs defined appropriately? 
Does the text convey a clear message to allow compliance? 
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4) Relationship between writer and reader (medical expert to lay person): 
Is the relationship between writer and intended reader clear and consistent? 
Is the person who is expected to take responsibility for any action clear?  
 
5) Headings (signposting for the reader): 
Are headings appropriate? 
 
6) Specialization of lexis: 
How technical is the vocabulary used in the texts? 
Is it appropriately presented? 
 
7) Lexical density: 
What is the average content density of the text? (analysis of the section 
concerning the route of administration of the medicine). 
 
8) Format: 
What is the length, layout, font/type size and other visual aspect of the 
document? 
Are there pictures and do they aid comprehensibility? 
 
3.3 The Corpus (PILs) selected for the study 
The corpus of  PILs selected for this analysis covers a good variety of 
products - some for serious and some for less serious illnesses, both for  
prescribed (P) and over-the-counter OTC medications . The dates of 
revision (last approval on behalf of the authoritative committees) go from 
February  2008  to February  2012. The PILs are the original medicinal 
leaflets (see index section including copies of the corpus), which were 
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supplied to me by friends residing in the UK. They may however, be 
downloaded, in their updated versions, from the electronic medicine 
compendium at : http://www.medicines.org.uk/emc/  
The sixty PILs analyzed are those that accompany the following 
medicines with indication of the therapies and the date of revision of the 
leaflet: 
 
 
    Name of medication 
 
Treatment uses 
 
Last revision of 
leaflet 
Adenuric tablets (gout) Aug 2010 
Advodart capsules (prostate) Mar 2010 
Alendronic Acid (osteoporosis) Nov 2010 
Amlodipine (high pressure) Sept 2010 
Aspirin Enteric Tablets (antiplatelet) May 2009 
Aspirin tablets (anti-inflammatory) Nov 2010 
Atarax Tablets      (urticaria) Sept. 2008 
Azathioprine Tablets (immunosuppressant) July 2008 
Benadryl Plus (hay fever) Sept. 2008 
Benylin (children’s chesty cough) April 2008 
Buscopan tablets (antispasmodics) Oct 2010 
Butrans Trans. patches
  
(analgesics) Jan. 2009 
Cefalexin Capsules (bacterial infections) Oct. 2009 
Celluvisc eye drops (eye irritation) Nov 2011 
Citalopram (anti-depressant)  July 2010 
Clopidogrel Tablets (thrombi)         July 2010 
Coaprovel (hypertension)         Jan. 2010 
Co-codamol Tablets (moderate pain) Feb. 2011 
Detrusitol (anti-muscarinics) Sept 2010 
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Dulcolax tablets (laxative) Feb 2011 
Ezetrol   tablets (high blood pressure) Mar 2010          
Finasteride (prostate) July 2010 
Flecainide Acetate 
tablets 
 (fast heartbeats)  Jan 2011 
Flucloxacillin Capsules (penicillin antibiotic) Jan. 2009 
Half Sinemet CR 
Tablets 
(Parkinson’s disease) Nov. 2009 
Hydrocortisone ointment (skin inflammation) Sept. 2009 
Istin (chest pain) March 2010 
Lamictal tablets (epilepsy) June 2011 
Lercanidipine Tablets (high blood pressure) Feb. 2009 
Lipitor (cholesterol)  March 2011 
Liquifilm tears (dry eyes) Feb. 2009 
Lisinopril tablets (high blood pressure) Aug 2010 
Losartan Potassium (hypertension) Jan 2010 
Macrodantin (infections) Feb 2012 
Metoprolo Tartrate (high blood pressure) Jan. 2009 
Multaq (anti-arrhythmics) Dec. 2009 
Naproxen tablets (steroidal anti-inflammatory) Feb 2010 
Neurpro transdermal 
patch 
(Parkinson’s disease) Nov. 2010 
Nurofen for children (anti-inflammatory) Mar 2010 
Nystatin Oral 
Suspension 
(anti-fungal) Aug. 2008 
Omeprazole capsules (stomach acid reducer) Nov 2010 
One- Alpha Capsules (osteodystrophy) Feb. 2009 
Paracetamol  caplets (anti-inflammatory) Mar 2010 
Phenergan Tablets (allergic conditions) March 2008 
Phorpain gel (anti-inflammatory) July 2010 
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Piriton tablets (allergy) May 2010 
Prednisolone tablets (cortisone for a variety of 
ailments) 
July 2010 
Premique Tablets (hormone replacement) April 2010 
Propranolol tablets (high pressure) Sept 2010 
Ramipril capsules (heart failure) Sept 2010 
Simvastin (cholesterol)  Nov  2011 
Temazepam Tablets (insomnia and anxiety) April  2009 
Tritace Tablets (hypertension) Feb. 2009 
Ventolin Evohaler (asthma symptoms) June 2009 
Viscotears (ocular lubricator) Dec. 2008 
Voltarol thermal patch (muscle relaxation) July 2010 
Warfarin Tablets (anticoagulant) April 2008 
Xalatan eye drops (ocular hypertension) Nov 2010 
Zoton Fas Tab (stomach acid reducer) July 2011 
Zovirax (cold sores) Nov. 2008 
 
Tab. 3.2 Corpus of study
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CHAPTER FOUR 
 
PRESENTATION AND DISCUSSION OF RESULTS 
 
The corpus was approached by reading all the 60 PILs thoroughly first, 
and then by reading each PIL separately. In the first part, the 
macrostructure was identified, then each macro-structural section was 
studied to detect the move structure. The moves were then put in relation to 
what the text was rhetorically trying to achieve. The findings from the 
analysis were then divided into features, and finally, the results identified in 
all the PILs were compared in order to answer the research questions: 
writer/reader objectives fulfilment; patterns in the text; features likely to 
further user-friendliness (patient-centeredness) and/or likely to hamper 
user-friendliness. Being the PIL a highly functional text, divided into seven 
mandatory functional sections (established by the EU guideline/template) 
and being the challenge of writing user-friendly PILs very much associated 
with the function of each section, it was essential to see how the purpose of 
each section was or was not successfully fulfilled. 
In what follows, a number of examples are provided to illustrate 
formulations identified in the leaflets that, according to previous research 
on accessibility and written patient information (see former Chapters), are 
considered to be user-friendly, thus, patient orientated and understandable 
to the general public. 
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4.1 Organization of the text and the rhetorical functions 
All the PILs analysed were printed on single sheets but had a wide 
range of dimensions. The seven sections were identified in all the leaflets 
except for one -Voltarol Thermal Patch-, (see Fig. 4.1), hence, making 
them rather conventional in their genre. The sections followed this order: 
a) introduction to inform the consumer;  
b) background of the medicine to define/explain/describe in general;  
c) warnings and precautions to inform/instruct/explain;  
d) constraints on patient behaviour -including information about 
medicine  interaction- to instruct/explain;  
e) account of side-effects to explain/describe/instruct;  
f) storage instructions to instruct ;  
g) further information to describe the medicine in detail and offer the 
consumer clinical contact. 
There was not a large degree of variability between the leaflets as 
regards to the incidence and sequence of the moves. Only three PILs 
slightly differed from the rest: Voltarol Thermal Patch which contained 
five short sections and a brief boxed opening section introducing the name 
and strength of the medication; Prednisolone (see Fig.4.6) which also 
included a headline section; and Ventolin Evohaler which also added the 
Asthma Control Test and its score at the bottom of the leaflet to be cut out 
and kept (Fig.4.2)  
The sections in Voltarol  were divided as follows: what the medication 
is for; how to use the patches; when not use the patches (precautions); what 
not to do with the medication; storage of the leaflet till the medication has 
ended and further information on the next page of the PIL to inform about 
the composition, manufacturer, distributer and  the last revision date of the 
leaflet: 
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Fig.4.1  Voltarol Thermal Patch PIL (front page and back page). 
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Fig. 4.2  Ventolin Evohaler PIL (bottom of front page and bottom of back page) 
 
All the other 57 PILs of the corpus contained seven identified sections, 
and the ordering of information was quite consistent between the 
documents.  The sections are now presented one by one. 
 
Section 1 
The leaflets opened with the section that presents the name, the 
strength, pharmaceutical form, and active substance of the medicine, as in 
the following: 
 
Example 1:  
  
 
 
 
 
(Lercanidipine) 
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Only 1 PIL, Istin, included the pictures of the packets available with the 
active substance, instead of stating the strength and pharmaceutical form 
verbally: 
 
 
 
 
(Istin) 
 
Straight after, there is also a preamble which instructs the consumer on 
how to engage with the leaflet and with the medicine s/he is about to take 
and to contact the doctor if there happen to be any doubts. This is defined 
as the bullet point section at the beginning of all PILs as shown in the 
example: 
 
Example 2 
       
 
 
 
 
 
(Zoton Fas Tabs) 
 
Finally, in this first section there is a table of contents, from 1 to 6, as an 
introduction to the whole leaflet: 
 
 
 
 
 
Chapter 4: Presentation and discussion of results 
 
89 
 
Example 3 
 
 
 
 
 
As mentioned in 3.1.8, the guidelines recommend judicious use of 
colour which may help to emphasise some key messages. The following 
are other examples of contents listed in coloured shaded boxes, or coloured 
print on white background:  
 
Examples 4 
 
 
 
 
 
 
 
 
 
(Lercanidipine) 
 
 
 
 
 
 
 (Adenuric) 
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Most PILs followed the above examples where the contents are 
presented as a list, not necessarily in shaded coloured boxes, or blue print, 
but with numbers to give an overview of what the leaflet will explain after. 
Only 4 of the leaflets did not have a table of contents: Aspirin Gastro-
resistant Tablets, Benadryl Plus Capsules, Benylin and Lisinopril tablets 
(see index section). In the example that follows, the patient/reader is asked 
to read the leaflet carefully before taking the medicine but the list of 
contents is left out,  
 
Example 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Benadryl) 
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Most of the text in the introductory section consists of standard phrases 
taken from the EU template and there is little variation between the leaflets. 
However in the Lamictal PIL there is an instruction to call a hotline, if the 
consumer finds the leaflet difficult to see or read, straight after the list of 
contents. The consumer  is asked to give specific information about the 
strength of the tablets and the reference number so that a reply may be 
given appropriately: 
 
Example 6 
 
               
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It is also made clear that this service is only reserved for residents in the 
U.K. free of charge.  
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Section 2 
The next section describes what the medicine is (the group of 
medicines which the product belongs to), explains what the medicine is 
used for, how it works, and/or what is expected from it. 
Example 1 (What the medicine is) 
                 
 
 
(Liquifilm Tears) 
 
Examples 2 (What the medicine is used for)  
 
 
 
 
 
   (Buscopan)                
 
 
 
 
 
 
 
 
 
                 
(Prednisolone) 
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Examples 3 (How the medicine works and its expected effect) 
 
 
(Flecainide Acetate PIL) 
 
 
 
 
 
(Ezetrol) 
 
Section 3 
Section three regarding ‘constraints on patient behaviour’ is a warning 
to consumers who are about to take the medicine. According to Sless and 
Wiseman (1997: 42), this section is a ‘safety net for cases where consumers 
have not informed their doctor about important conditions that might affect 
their use of a medicine’. Thus consumers are instructed to avoid taking the 
medicine and to contact the doctor if certain conditions apply to them, e.g. 
if they are allergic to the active ingredient, belong to a certain category of 
users (the elderly, children, pregnant, breastfeeding), have pathological 
conditions, operate machinery, take other medicines, alcohol and 
foodstuffs, which may interact negatively with that medicine. This section 
tends to be one of the longest and the one with most information in it (the 
heavy section of the PIL). The information about effects consists of 
conceptual information which is split up into modules, meaning that the 
information is transferred into relevant questions of the user, that is, from 
the perspective of the patient. The linguistic means used to convey risk 
conceptual information uses clear signal words with a warning character, 
Chapter 4: Presentation and discussion of results 
 
94 
 
sometimes pictograms as well. Because this part of the PIL is dense and 
full of information, often the patient is at risk for missing essential 
information because of its overload. This is the reason why, as 
recommended by research, current PILs tend not to exaggerate on risk 
matters. In general there is a lot of recognition of the importance of 
informing people about the risks, as well as benefits of their treatment, but 
the information must not frighten the consumer who may give up taking the 
medicine after all. In this section the imperative form is used to realize 
instructions such as: ‘Do not take this medicine and/or tell your doctor 
if...’. The patient is addressed directly through the second person pronoun 
and this is another way of promoting patient-centeredness, so as to give the 
text a less formal tone.  
Other features include lay terms and colloquial everyday language, simple 
active syntax, and bullet points that highlight key messages (i.e. special 
conditions and precautions which may apply to the individual consumer): 
 
Examples 1 
                
 
 
 
 
(Zoton FasTabs) 
 
 
 
 
 
 
(Phorpain Gel) 
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(Propranolo) 
 
 
 
 
 
(Macrodantin) 
 
 
 
 
 
 
 
(Aspirin Enteric) 
 
There are many examples of direct instructions with an easy-to-
understand explanation of why the patient should inform the doctor about 
other medicines. The following piece of text taken from Zoton Fas Tabs, 
illustrates the positive trend of trying to provide consumers with 
information which is relevant for their compliance:  
 
Example 2 
    
(Ramipril) 
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Section four 
The purpose of section four is to instruct the patient on how to take the 
medicine correctly and how to act in case he/she does not take the medicine 
correctly, or perhaps has any doubts on the use of the product.  
Information in this section includes dosage (often in relation to certain 
categories of users), method and frequency of administration, the duration 
of treatment, the expected effect, instances of forgetting a dose, over 
dosage and the way treatment should be stopped. Positive features in this 
section include imperative clauses for realizing straightforward instructions 
(e.g. how to take the medicine) and simple and short sentences (often in 
bullet points) which explain, in a colloquial and direct way, how the 
medicine should be taken and what may happen if procedures are not being 
followed: 
 
Examples 1 
 
 
 
 
(Omeprazole) 
 
 
 
 
 
 
 
(Phorpain) 
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(Propranolol) 
   
 
 
 
 
 
 
(Zoton Fas Tabs) 
 
 
 
 
 
(Losartan Potassium) 
 
Section five 
The purpose of section five is to describe, explain, and grade some of 
the undesirable side effects that may occur, and to instruct the consumer to 
take action if a side effect occurs (e.g. to contact the doctor or pharmacist). 
The information about effects consists of conceptual information which is 
split up into modules, meaning that the information is transferred into 
relevant questions of the user, that is to say, from the perspective of the 
patient. The linguistic means used to convey risk conceptual information 
uses clear signal words with a warning character, sometimes pictograms as 
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well. This section also entails the risk that perhaps the patient will miss 
essential information because of information overload. In general there is a 
lot of recognition of the importance of informing people about the risks, as 
well as benefits of their treatment. There is, however, growing evidence 
from both everyday experience and empirical studies, that people’s 
interpretations of risk messages are also significantly influenced by the 
particular way in which the information is presented. The information 
given about side effects is very important for the patient who wants to 
satisfy his/her hunger to be further informed of what possible effects may 
occur. The ability of the writer (expert) is to provide patients with sufficient 
information, but at the same time, that information will not lead to 
increased anxiety about their illnesses or treatments. Good information 
leaflets should reduce anxiety and should not result in an increase of side 
effects, but aid patients to participate more actively in their own treatment. 
In most current PILs presentational factors for describing probability 
information is presented both verbally and numerically. The grading of side 
effects may be a potential source of confusion but changes have been made 
and two common ways of presenting risk probabilities are applied: verbal 
labels, such as ‘common’ or ‘rare’, and numerical terms such as ‘1 in a 
100’ are mostly used now. In fact, the European Commission (2001), 
specifically recommended the use of five such descriptors -‘very common, 
common, uncommon, rare, and very rare’-. Before the introduction of 
natural frequencies, such as: 1 out of 100, or 1 out of 1000, to describe 
probabilities of risk, the use of percentages showed to give rise to particular 
difficulties because people would over-estimate risk, thinking for example 
that 10% meant much more than what it really related to (Berry, Raynor 
and Knapp, 2003). Thus, positive framing has shown to affect people’s 
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treatment preferences and improve their understanding of the information 
presented (Armstrong, Shwartz, Fitzgerald, cited in Berry, 2006: 122). 
About 32 of the PILs analysed have shown to carry a successful 
grading as regards to probability information, where a division into very 
common, common, uncommon, rare and very rare side effects including a 
graduation of frequency (by number of persons affected) was presented in a 
straightforward colloquial manner (see examples): 
 
Examples 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Lamictal) 
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 (Azathioprine) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Alendronic Acid) 
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In Aspirin Enteric Tablets (see example below), Omeprazole, Phorpain 
gel, Paracetamol caplets, Piriton allergy tablets, Flecainide, Naproxen, 
Propranolol tablets, Lisinopril tablets (see PILs in appendix), and Voltarol 
(see Fig. 4.1), neither verbal nor numerical descriptors, of side effects were 
present: 
 
Example 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
(Aspirin EntericTablets) 
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Two PILs, Finasteride and Nurofen for children, carried the verbal 
descriptors but not the numerical ones (see examples): 
 
Examples 4 
 
 
 
 
 
 
 
(Finasteride) 
 
 
 
 
 
 
 
 
 
 
(Nurofen for children) 
 
Section six 
Section six has the ‘move’ which instructs the consumer on how to 
store the product safely and effectively, and how to dispose of the medicine 
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in a safe and environmentally friendly way. It also instructs the consumer 
on how to act if the product has reached its expiry date or shows visible 
signs of deterioration: 
Example 1 
 
 
 
 
 
 
 
 
(Citalopram) 
 
Much of the text in this section of the leaflet, draws on standard phrases 
from the EU template as: ‘keep out of reach and sight of children’. The 
PILs in the corpus do, in fact, follow that template, except for Paracetomol 
that has reformulated the phrase above and also carries a symbol 
representing storage measures beside the verbal instructions: 
 
Example 2 
 
 
 
 
The Phorpain PIL has also added a boxed warning as follows: 
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Example 3 
 
 
 
 
Section seven 
Section seven concerns further information. 
The purpose of this final section is to describe what the medicine 
contains, what it looks like and to list the content of the package. It also 
includes the name and address of the marketing authorization holder 
(MAH) and manufacturer, product licence number and the date of the last 
PIL revision (see Chapter One).  
All the PILs analysed contained the details stated above. The following are 
some examples: 
 
Examples 1 
 
 
 
 
 
 
 
 
 
(Flucoxacillin) 
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Lipitor and BuTrans also include the pharmaceutical companies which 
distribute that medicine with the same or different name in other countries 
of the Member States: 
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Two PILs, Multaq and CoAprovel, supplied the local representatives of 
the Marketing Athorisation Holder (MH) in other countries of the EU, and 
support the information with the  inclusion of the EMEA website: 
 
Examples 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Multaq) 
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(CoAprovel) 
 
In sum, the results of this part of the analysis regarding the organization 
of the texts and the functions, showed that apart from one, (Voltarol), all 
the PILs presented the moves in quite a standard and linear way. The 
rhetorical functions (explain/define, describe, inform, instruct, offer, 
monitor) were identified according to the generic structure moves 
(introduction to the medicine, background, dosage, constraints on patient 
behaviour, side effects, storage, further information about the medicine) 
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which all, more or less, followed the same order appropriately. In most 
PILs, patients were being offered a service (‘seek the advice of your doctor 
or pharmacist...’), whereas in others they were being instructed to initiate a 
meeting (‘tell your doctor’). The instructions regarding responsibility were 
quite clear as well, such as ‘The usual dose is 30mg oro-dispersible tablets 
every day to start with, then depending on how you respond to Zoton 
FasTab the dose that your doctor sees best for you’, (see PIL in appendix). 
Thus, the ‘doctor’ is specified for being responsible for making that 
decision. Language denoting uncertainty followed the same order in 32 
PILs because they noted, with verbal descriptors, that the frequency of a 
complication was from ‘very common to very rare’ and clarified this to 
mean that it occurred in 1 or more of 10 patients treated, or, in less than 1 
of 10000 patients treated. It has been noted, therefore, that there seems to 
be a clear guidance in helping the patient to understand what to do with the 
information presented in most of the PILs examined.  
Relating the above results to the notion of generic potential as 
elaborated by Paltridge (1997), drawing on Hasan (1989), the PILs carried 
the following  generic structure: [IM] ^ [BM] ^ [WP] ^ [CB] ^ [AS] ^ [SI] 
^ [FI]. The letters in the square brackets are the moves: introduction to the 
medicine, background of the medicine, warnings and precautions, 
constraints on patient behaviour, account of side effects, storage 
instructions and further information. The identified moves followed a fixed 
sequence illustrated by ^ in the above representation. 
 
4.2  Metadiscourse  (The language of PILs) 
It is long known in communication studies that any form of 
communication occurs at two levels: the content level and the relationship 
level, in other words, “the relationship that always takes a bold hand in 
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determining the content” (Brown & Keller, 1973: 166). This concept of the 
relationship between the interactions is essential to the definition of 
interaction, “the network of relations between the participants (writers and 
readers) in the communicative event through the text” (Harvey, 1995: 189). 
The definition reflects the above two levels of communication but it also 
emphasizes how the ‘bold hand’ of the relationship with the reader is used 
to shape the writer’s message. 
The PILs analysed in this study seem to be highly interactional, and 
exhibit an ‘over-signalling’ of the reader’s responses and reactions 
(Thompson & Thetela, 1995 cited in Sultan Al- Sharief, 1996: 13). These, 
written for a non-specialist audience are characterized by a relatively 
simple language in rhetorical, lexical, and syntactical terms (Myers, 1994: 
179). Such language does not, however, entail unsophisticated objectives or 
facts of less credibility. On the contrary they contain a lot of medical facts 
following some of the conventions of scientific writing which mingled to 
the patient’s informational needs, reflect the complex role of meeting their 
objectives. The comprehensibility of PILs as a function relies a lot on the 
interaction of the reader with the text, hence, including readers’ 
constructions of a text. The communicative success of a PIL is not always 
guaranteed even when the readability and comprehensibility are high 
because the reader may construct a meaning from the text that is coherent, 
but is divergent from that intended by the writer, and this gives rise to an 
inappropriate response. This is however different from the situation in 
which the reader comprehends the intended meaning but makes a 
considered judgment not to comply with the message. As already 
mentioned, it is very frequent to find readers who will not systematically 
read through the text from beginning to end. When reading a PIL a patient 
might begin by scanning the leaflet, seeking those parts that appear most 
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relevant or interesting, and may consciously or unconsciously skip over 
portions of the text. This behavior with PILs, which is not a linear reading 
process, makes communication less effective. Hence, the message in most 
of the updated PILs, and those studied in this research, seems to be 
appropriate and quite clear, however, it is necessary to say, as argued by 
Garner et al (2011) the PILs’: 
“[…] communicative effectiveness depends on the reader’s 
‘cognitions’ (e.g. expectations, understanding), ‘affect’ (e.g. 
relief, concern, worry) and often ‘intention’ and ‘behaviour’ 
(e.g. taking a pill before eating)”.   
(Garner et al. 2011: 8) 
 
Research into communicative effectiveness explores the nature of the 
readers’ actual or intended responses. Any form of communication gives 
rise to variant interpretations, as a result of the expectations, motivations, 
prior knowledge and personal circumstances of the addressee, together with 
other factors. As with other types of effectiveness in relation to healthcare 
(e.g. clinical effectiveness, cost effectiveness’, a PIL should be, and rightly 
is, assessed on the basis of specified outcomes. This is the reason why user-
testing is carried out (see Chapter One), because the notion of ‘usability’ is 
explored and identified within a concrete context, also through human-
computer interaction when systematical examining of the actions are 
evaluated and not only reported comprehension. 
Some general communicative aims frequently found in medical leaflets 
(however, not comprehensive) are: 
- Providing a scientific background of the health problem and the 
medicine in question. 
- Preparing the patient for the treatment by providing information about 
how to start the treatment. 
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- Persuade patients to stop unhealthy habits or at least take steps that 
will make them less harmful. 
- Giving practical advice that will help to avoid complications of the 
illness or will complement the treatment. 
- Arguing against some misconceptions about the disease and/or its 
treatment. 
 
All the above have the function to specify the intended objectives to 
help the reader identify the medicine, determine whether it is safe, act 
correctly in the case of complications and how to use the medicine, hence: 
“understand, respond and comply with the PIL” (Garner et al. 2011: 9). 
After reading the leaflet the patients should be able to: 
1) Know whether the medicine fits their complaints. 
2) Whether or not they can safely take the medicine. 
3) How to use the medicine. 
4) What side effects may occur and what to do in case they occur. 
5) Whether using the medicine may affect certain activities in 
everyday life.  
6) How to store medication. 
 
All of the PILs studied carried the above information (as explained in 
4.1). Some had more detailed information, especially the POM leaflets, but 
both POM and OTC PILs were rather clear and straightforward as far as 
their contents was concerned. The leaflets all opened with  the following 
statement: 
Read all of this leaflet carefully before you start taking this medicine. 
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The following are further examples of the PILs analysed, responding to 
the general purposes of the leaflets. They may be viewed in the index 
section. 
 Does the medicine fit? 
Dulcolax Tablets are used for relief of constipation. 
Piriton Allergy Tablets are used for the allergic symptoms of hay fever and other 
allergies. 
The name of your medicine is Flecainide Acetate 50mg or 100mg Tablets 
(called flecainide throughout this leaflet). This belongs to a group of medicines 
called anti-arrhythmic. 
 
 Can you take this medicine? 
Before you use Phorpain gel Maximum Strength: DO NOT use Phorpain Gel 
Maximum Strength if: you are allergic to ibuprofen, aspirin or similar medicines 
or any of the ingredients in this gel.  
 
Anti-epileptic medicines are used to treat several conditions, including epilepsy 
and bipolar disorder. People with bipolar disorder can sometimes have thoughts 
of harming themselves or committing suicide. If you have bipolar disorder, you 
may be more likely to think this: 
- When you first start treatment 
- If you have previously had thoughts about harming yourself or about suicide 
- If you are under 25 years old 
Lamictal should not be given to people aged under 18 years o treat bipolar 
disorder.  
 
 How do I use this medicine?  
How to use Nurofen for children 3 months to 9 years strawberry. 
Using the heat patch (Voltarol). 
Take Ezetrol at any time of the day. You can take it with or without food. 
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 What side effects may occur? 
Possible side-effects 
Like all medicines, Detrusitol XL can cause side effects, although not everybody 
gets them. 
Uncommon side-effects (more than 1 in 1,000 patients but less than 1 in 100 
patients) are: weight gain, increased appetite, change in blood sugar levels 
(diabetes) of which a symptom may be excessive thirst, increased blood fat 
levels. 
If any of the side effects gets severe, or if you notice any not listed in this 
leaflet, please tell your doctor, family planning nurse or pharmacist. (Adenuric). 
 
 Can this medicine affect everyday life activities? 
Driving and using machines 
Ezetrol is not expected to interfere with your ability to drive or to use 
machinery.  
Pregnancy and breast-feeding 
If you are pregnant, breast-feeding or if there is a chance you might be pregnant 
ask your doctor for advice before taking this medicine (Zoton Fas Tab). 
 
 How do I store this medicine?  
Store in a dry place. Protect from light. Do not store above 25°C (Propranolol).  
Store in the original packaging to protect from light and moisture (Paracetomol). 
 
Patients are also warned not to take medication after the expiry date.  
EXP stands for expiry and it is clearly market on the carton, and blister of 
the medicine. The expiry date does not indicate the day, only the month and 
year, but expiry  refers to the last day of the month stated. 
The readers will surely understand the information presented more 
efficiently if at the basis of their understanding there lies the schema 
mentioned before. It is the reader’s response that determines the endpoint 
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of communication. Therefore, the meaning of the PIL is not constituted by 
what is encoded by the writer, but by the patient’s behavioural, cognitive, 
and/or affective response: the reader knows that X and Y are symptoms of 
side effect Z. S/he knows that this side effect must not be neglected, and 
s/he is willing to contact the doctor to inform him/her about the side effect 
to discuss the consequences (Lentz & Pander Maat, 2001, cited in 
Bongaart, 2009: 9). If there is a lack of comprehension, due to various 
reasons, (some mentioned before), there is no-affective response. 
 
4.3  Relationship between writer and reader (medical expert to lay 
person) 
Most current PILs which have undergone user-testing are defined as 
being more patient-centred than the former ones. This means that patients 
are at the centre of the medicine-taking process (Raynor et al, 2007). The 
point of departure of the utterances is the patient and his or her immediate 
situational context and presumed state of knowledge rather than the 
medical situational context and medical knowledge. Thus, whenever new 
information (e.g. about the medicine and how to take it) is presented to the 
patient, this information is coupled with assumptions about the patient’s 
presupposed knowledge and immediate context (as mentioned before). 
Jensen, a Danish expert gives advice on knowledge communication, and 
suggests that:  
“The equation for successful communication is actually very 
simple: new knowledge on top of old knowledge makes me 
wiser, new knowledge on top of new knowledge makes me 
feel more stupid”.  
(Jensen 2001, translated from Danish by Zethsen and Askehave 2009: 101) 
 
In PILs ‘patient-centeredness’ is manifested linguistically through 
various linguistic features. A typical way of constructing experience in our 
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part of the world is through processes, participants and attendant 
circumstances (Halliday 1994). In most of the PILs here analysed there was 
a frequent use of a question-answer format, complying with legal 
requirements. This sort of construction in Halliday’s words (1994: 140), is 
‘congruent’ because there is a close relation between the actual event 
(someone is doing something, somewhere) and the lexico-grammatical 
structure with ‘participants’, ‘processes’ and ‘circumstance’, thus 
resembling or imitating the patient’s real life experience. This shows that 
the author had considered the relationship between writer and reader. 
Furthermore, the patient is assigned the semantic role of the main 
participant who performs an action which is common and recognizable to 
the average patient as in going to the doctor.  
For example :‘You (participant) may have gone (process) to the 
doctor (circumstance’/location) because (conjunction) you (participant) 
had (process) a stomach ache (participant)’. Thus, throughout the leaflets, 
the reader was almost  referred to as ‘you’. 
Differently from other technical texts, which tend to prefer a 
nominalized, objective and passive style with dense, complex noun groups, 
in PILs, preference goes to what Flower et al. (1983) cited in Killingsworth 
(1987: 105) refer to as ‘functional prose’ that is to say ‘structured around a 
human agent performing actions in a particularized situation’, trying to 
replicate the ‘real world’- a world of action, connections and relations 
(ibid.).  
Another important feature for considering the role relationship in 
current PILs (and those analysed in this study) is that the patient is always 
addressed to through the second person pronoun. According to a study on 
the changes in subjectivity and stance, Sanders and Spooren (2010), discuss 
that researchers have observed ‘informalization’: a shift of stylistic 
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preferences in written discourse towards a more conversational, or oral 
style. Citing Pearce (2005), Sanders and Spooren (2010: 2) say that the 
increase in ‘informalization’, is reflected in linguistic characteristics such 
as the number of nominalizations, and the increase of the use of first and 
second person pronouns. 
Thus, whenever possible, the second person pronoun ‘you’ is used in 
the PILs to address the patient rather than the impersonal choices of ‘one’, 
‘the patient’, or even a passive construction, which is common in medical 
texts, where ‘the effect or result of an action is almost always more 
important and therefore of greater interest to the reader than knowing who 
or what performed the action’ (Sagar et al. 1980). The grammatical choice 
accentuates the fact that the PIL is a functional text written for your sake 
and dedicated to your compliance rather than for the sake of the legislators, 
the medical community, etc. As mentioned the use of the pronoun ‘you’ 
gives the text a less formal orientation to address the patient and this makes 
him/her even more responsible for taking a decision to take the medicine 
(see examples): 
 
Examples 1 
 
 
 
 
 
(One-Alpha) 
  
 
(Ezetrol) 
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(Premique) 
 
 
 
 
 
 
 
 
 
 
(Amlodipine) 
 
As with the second person pronoun, the unmarked way of issuing a 
command is through the use of the imperative mood. Being an instructive 
text, where action is required within the PILs on behalf of the patient, the 
command is realized in the most direct way, namely through the imperative 
mood. The idea is to get the patient to do something, carry out an action. 
 
Examples 2 
 
 
 
(Aspirin Enteric Tablets) 
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(Macrodantin) 
 
 
 
 
  (Leicanidipine) 
 
 
 
 
 
    (Zoton Fast Tabs) 
 
   
 
 
(Liquifilm Tears)  
 
 
 
(Flecainide) 
 
 
 
 
(Tritace) 
 
 
(Azathioprine) 
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(Lisinopril) 
 
This grammatical choice accentuates the fact and makes it explicit that 
the PIL is a functional text that requires action on the part of the patient. 
The PIL, therefore, is a very action-oriented and ‘direct’ text in the 
sense that it requires compliance and action on behalf of the patient. 
Zethsen and Askehave (2009: 102) argue that the realizations of mood and 
experience mentioned before, may however have a downside, namely that 
the text becomes too direct and ‘pushy’, setting up a very authoritarian 
relationship between the ‘knowledgeable’ writer, talking down to the ‘less 
knowledgeable’ patient. (e.g. You must tell your doctor if....; Take the 
capsules exactly as directed by your doctor; Your doctor will decide 
whether...Do not stop taking X unless...). But it is also true that writers of 
PILs try to make up for this unequal relationship by employing different 
types of modality which serve to tone down the force of the proposals, 
commands or propositions in the text.  
 
Examples 3 
 
 
 
(Prednisolone) 
 
 
(Lisinopril)  
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The above interpersonal features: ‘please inform your doctor...’, ‘you 
may need to inform your doctor...’, convey a less demanding tone, and 
were present in most of the PILs analysed. However, 7 PILs did not use 
‘please’ but ‘tell your doctor’ or ‘talk to your doctor’: Lamictal, Aspirin 
Enteric Tablets, Aspirin Gastro-Resistant, Voltarol Thermal Patches, 
Ezetrol, Finasteride and Propranolol. These, in fact, carry a more 
authoritative tone than the others and may give the impression of ‘pushing’ 
the patient a bit too much to take action.  
 
Examples 4 
 
 
(Aspirin Enteric Tablets) 
 
 
 
(Lamictal) 
 
We can also notice the use of bold which emphasises the message and 
conveys a more commanding/authoritative tone: 
 
 
 
 
(Ezetrol) 
 
 
(Aspirin Gastro-Resistant) 
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4.4  The use of headings and headlines 
Many of the leaflets (46/60) used left-ranging headings with the 
remainder having centred ones and were phrased as questions or 
statements. 12 headings appeared on a shaded background box, e.g.: 
Benadryl, Bu Transdermal Patches, Co-Codamol, Flecainide Acetate, Istin, 
Lipitor, and Zoton Fas Tab; 10 headings in an non-shaded box, e.g.: 
Flucloxacillin, Lisinopril, Losartan Potassium, Ramipril,  Viscotears, and 
Warfarin. The other headings were not surrounded by a box, e.g.; Aspirin 
Enteric Tablets, Atarax, One-Alpha, Cefalexin, Clopidogrel 
Hydrocortisone Ointment, Multaq, Metoprolol, Phenergan, Premique, 
Tartrate, Temazepam. Ventolin Evohaler, Half Sinet CR Tablets. Some 
PILs used a combination of bold and italic print with variations of colours 
(black, brown, dark blue, light blue, red, white). Capitals were used in 
about 50% of the leaflets for the main heading and sub-headings (see PILs 
in the appendix section). 
Research suggests that lower case letters are easier to read (Hartley, 1994), 
so manufacturers tend to avoid unnecessary capitals for important 
information and long headings. The use of lower-case letters had also been 
recommended by the European Commission in 1998. 
Some of the headings are in bold to emphasize the information, however, 
there is not an exaggeration of the use of bold throughout the leaflets. 
As for headlines, (mentioned in 1.8) which appear at the beginning of 
the PIL, straight after the bulleted introduction preamble that engages the 
consumer with the leaflet, only 1 PIL, Prednisolone, included this section. 
Headlines are still not very common (Prof. Raynor, 2012, in an email sent 
to me). They were recommended by the MHRA in 2005 to anticipate what 
was to be mentioned in the body of the leaflet. Research (Dolk, 2009: 15) 
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has shown that, on one hand, the readers’ attention is drawn to the headline 
section due to the shaded box and its title ‘Important things you need to 
know’. On the other hand, the risk of the inclusion of a headline may be 
inefficient for the patients who will just read the headline section and forget 
about the rest of the PIL. This means that they are still not fully aware of 
the risks and benefits of taking that particular medication. 
The Prednisolone PIL, in this corpus, presented the headlines in a green 
shaded box followed by bullet points that summarise what is explained in 
detail in the body of the leaflet (Fig. 4.3):  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.3 Prednisolone PIL including headlines 
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4.5  Specialization of lexis 
The draft “readability guideline” recommends using simple words with 
few syllables in order to make the leaflet understandable for people with 
poor reading skills and/or poor health literacy. In addition, the sentences 
should not contain more than 20 words and numerous subordinate clauses 
should be avoided. It may be assumed that these recommendations go back 
to the MHRA’s publication of “Always read the leaflet” (2005) which 
details an evaluation for England and Wales stating that nearly half of all 
adults aged 16-65 were classified to have a skill level expected of 11 year 
olds. In a project work entitled Master of Drug Regulatory Affairs Dr 
Ursula Schickel, (2007) points out that: 
“A separate British survey came to the conclusion that highly 
educated patients do not mind if instructional materials are 
oversimplified for them. Actually, it is hard to believe that 
such a simple style and wording will be of benefit for the 
average of the potential patients and, even more important, will 
be accepted at all as patients might miss an adequate 
seriousness of the wording”.  
(Schickel 2007: 82). 
 
Dr Schickel also quotes Kenny et al.(1998), who found out that: 
“[…] a style which is too simple could sound patronizing and 
may lack interest and ‘authority”.…          (2007: 89). 
 
 
Although technical texts often do employ a wide range of specialized 
lexis, most of the 60 PILs analysed respond to the quotations mentioned 
above. Words and phrases were not very specialized and tried to suit the 
lay person’s needs. 
General terms were used for medical conditions, like ‘high blood 
pressure’, ‘kidney and heart problems’, ‘swelling of the throat’, etc. This is 
an interesting trend as it works against the precision sought after in medical 
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texts but makes sense from a patient’s perspective as it provides the patient 
with the level of precision and information he/she needs for taking action. 
Furthermore, if there is a need for introducing an exact medical term, the 
medical term is put in brackets after the lay explanation, or vice-versa, the 
lay term is explained in brackets. See examples: 
 
Examples 1 
 
 
 
 
 
Or 
 
...if you suffer from indigestion (dyspepsia)  (Aspirin Gastro-Resistant) 
Do not take Propranolol if you: are allergic (hypersensitive). 
A chemical called uric acid (urate)  (Adenuric) 
....diuretics (‘water tablets’) 
....euphoria (‘feeling high’)  (Prednisolone) 
....Palpitations (feeling your heart beat), fast or irregular heart beat, or low blood 
pressure (you may feel faint)  (Piriton Allergy Tablets) 
If you have a blocked bowel (intestinal obstruction)  (Dulcolax) 
(View the above PILs in the index section) 
 
In the following extract taken from the Metoprolol Tartrate PIL, there is 
a significant example of specialised words and their lay explanation inside 
or outside brackets (see example on next page): 
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Example 2 
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Another PIL that contained many specialized terms and their 
explanations was the Nurofen for Children, especially in the section 
concerning : What Nurofen for Children 3 months to 9 years Strawberry is 
and what it is used for, e.g.: diuretics, lithium, anticoagulants:  
 
Example 3  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Nurofen for children) 
 
From the examples given, it is clear that, the lexically difficult words are 
not isolated but embedded in an understandable context.  
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4.6  Lexical density 
The lexical density (average number of content words per clause) was 
carried out to determine how much conceptual load was identifiable. This 
was of interest given the particular combination of the relatively informal 
nature of the channel (a medical leaflet), the potential seriousness of the 
information for the patient, and the intricacies of the expert-lay 
relationship. Results showed that the majority of the PILs fell in the upper 
end of the scale, that is, away from the ‘spoken-like’ end of the continuum 
and toward the academic end (Halliday, 1985) (see examples). However 
there also seems to be a relationship between the move at the genre level 
and lexical density, because the analyses was carried out on the section that 
describes the background of the medicine, What X is and what it is used 
for, which is lexically dense. In the following examples of the corpus, the 
clauses have been copied and the lexical items are given in italics. 
 Examples 
 
 
 
Alendronic acid belongs to a group of non-hormonal medicines called 
bisphosphonates. Alendronic acid prevents the loss of bone that occurs in 
women after they have been through the menopause, and helps to rebuild 
bone. Alendronic acid reduces the risk of spine and hip fractures. 
 
Chapter 4: Presentation and discussion of results 
 
128 
 
 
 
Aspirin Tablets are used to reduce the likelihood of further heart 
attacks or strokes in patients with a previous history of these conditions, 
when taken regularly. 
 
 
 
Adenuric works by reducing uric acid levels. Keeping uric levels low 
by taking ADENURIC once every day stops crystals building up, and over 
time it reduces symptoms. Keeping uric acid levels sufficiently low for a 
long enough period can also shrink tophi. 
 
 
 Celluvisac is a tear substitute and contains the lubricant called 
carmellose sodium. It is used for the treatment of the symptoms of dry eye 
(such as soreness, burning, irritation or dryness) caused by your eye not 
producing enough tears to keep the eye wet. 
 
 
EZETROL works by reducing the cholesterol absorbed in your 
digestive tract. Ezetrol does not help you lose weight. 
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Prednisolone belongs to a group of medicines called steroids. Their full 
name is corticosteroids. These corticosteroids occur naturally in the body, 
and help to maintain health and well-being. Boosting your body with extra 
corticosteroid (such as Prednisolone) is an effective way to treat various 
illnesses involving inflammation in…. 
We notice an occurrence of 5/6 lexical items per clause. The findings 
showed that about half of the PILs carried from 5 to 7 and half from about 
7 to 9. If we consider the average number of content words per clause 
estimated by Halliday, (1996), between 3 and 5, 50% of these PILs are 
quite near, whereas the others are slightly away. The longer sentences do, 
in fact, contain more content words, on average from 7 to 9, as in the 
examples above. However although they may seem to carry a more 
academic-like language, the message conveyed is not very difficult 
compared to previous style and language of PILs. 
 
4.7  Format 
Document design issues such as layout, font size and style, and use of 
visual material are considered to have an important impact upon patients’ 
capacity to comprehend patient information leaflets (Schriver, 1997; 
Hartley, 1994, 1999). 
In written texts, emphasis is not only the counterpart of stress in 
speech; it also serves as a navigational aid. For instance, if important 
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warnings are presented in bold face, they can be found at a glance, even if 
they appear in an inaccessible location such as the middle of a paragraph. 
As in the case of indented lists, this benefit depends on using the device 
sparingly: if each page has dozens of emphasized phrases, the warning 
becomes a needle in a haystack. At an absurd extreme one might imagine 
an author emphasizing the whole text on the grounds that every word is of 
vital importance. Emphasizing an entire leaflet by formatting it in capital 
letters, for example would create a drawback because the reader would not 
be able to distinguish degrees of importance, and there would also be an 
unpleasant tone, just like a feeling of being shouted at. 
Therefore the design and layout of the information is crucial in helping 
patients to find and understand the important messages for safe use within 
the PIL. As stated in Chapter One, leaflets undergo user-testing trials, 
hence, before submitting a leaflet, manufacturers are asked to review the 
way in which the information is set out within the document and to take 
account of ‘best practice’ to comply with the new article 59 of Council 
Directive 2001/83/EC, and with the revised guidelines of the MHRA. 
As required by the recent PIL guidance (2012) manufacturers need to 
follow a common design and layout which include the following important 
aspects:  
• Font style and font size:  
“Typography can be defined as designing with type in order to 
communicate a message. The typeface used and other elements 
of graphic design such as colour of text need to be chosen with 
the audience in mind. When used well these aspects organise 
and communicate the information in a way which meets the 
needs of the reader. No matter how well written the text is in 
the PIL if it is set out in a typography which is difficult to read 
it is unlikely that patients will take the time or be encouraged 
to read it”.  
(PIL Guidance 07/12 final p. 6).  
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• Headings and sub-headings including consistency of placement  
• PIL dimensions including whether the document is laid out in 
portrait or landscape format and number of columns  
• Use of colour and choice of colour  
• Style of writing and language used  
• Layout of critical safety sections of the PIL  
• Use of pictograms 
 
And, some of the key points that manufacturers must note which help 
patients to navigate the information are: 
• headings must be placed consistently and stand out by using either 
a larger font or by emboldening the text; 
• judicious use of colour can help but it must not make a contrast; 
• patients like an index, so this is very important if a booklet format 
is being used which is known to be more difficult to navigate. 
• The text size used should be as large as possible and there should 
be a good use of white space. Dense text means patients lose 
concentration and therefore cannot find the information required. 
• Long lists of side effects are frightening and short bullet points 
have been found to be helpful. The side effects should be grouped 
according to seriousness and allow patients to immediately 
distinguish when to take urgent action. 
• Related information should be located together and not split over 
different columns or sides of the leaflet. 
• Information should not be repeated as this is known to confuse. 
• Information which appears before the index or in a box is 
overlooked by patients so these devices should not be used. 
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The PILs analysed presented several designs, however the order of 
information was quite standard. All 60 were printed on single sheets but 
with different dimensions. 25 had a portrait format and the rest had a 
landscape model, (see Figures 4.4; 4.5). Most of them were folded in a Z 
shape, except for 3 which were A4 sheets double-folded. None of the 
leaflets were transparent, nor used glossy paper which is known to make 
readability more difficult (Guideline 2001).  
The readability guideline recommends dark text to be contrasted against a 
light background as a general rule, in rare occasions the opposite may be 
adequate to highlight particular warnings. Different colours may be used 
for displaying headings or important information clearly and easily 
recognisable, whereas red colour print should be reserved for very 
important warnings only.  
Colour is both a way of emphasising a message and of communicating 
in an emotional manner in a presumably universally way. Since it has been 
criticised that the information in package leaflets is often understandable 
but hard to find, associating certain sections of a package leaflet with 
corresponding colours might be of benefit to improve their readability 
(Schickel, 2007).  
The colour in the 60 PILs studied was mainly black on white paper, 
however 8 used light blue on white paper:  Adenuric, Aspirin Enteric 
Tablets, BuTrans, Istin, Losartan Potassium, Multaq, Phenergan, Tritace 
and Voltarol;  1, Benadryl, used dark blue and light green, and Benylin, 
used violet and red (see PILs in the index section).  
As for the names of the medication in the headings,1, Zoton, had a dark 
brown shaded box with white writing;  2, Co-Codamol and Flecainide 
Acetate, had white writing in a dark grey shaded box; 1, Nystatin used 
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black on light grey;  3, BuTrans, Coaprovel and Istin; had blue writing in a 
light blue shaded box.  Lipitor and Lecaniside were the only PILs to use red 
colour print for the headings and for the illustrated symbols, (important 
information) and  white print on a red background for the numbered 
sections. There was no contrast between the colours, therefore the 
background was clearly distinguished.  
White space inside the text was used quite appropriately according to 
the guidelines:  
“White space within the written text is helpful in creating a 
feeling of openness about the information being presented” 
  (PIL Guidance 07/12 final p. 7). 
As for the use of columns and spacing, the PIL Guidance states: 
“The use of columns which are familiar to most readers 
through newsprint help readers to easily assimilate 
information. Line length and line spacing are important aspects 
of design and should be taken into account when deciding on 
an appropriate layout”. 
 (PIL Guidance 07/12 final p. 7) 
 
The PILs in this study showed to prefer a column format which is 
found to help the reader navigate the information. It is thought (User-
testing, Raynor 2009) that patients feel more comfortable with landscape 
layout as opposed to portrait format, especially when printing the heading 
over the entire breadth as this resembles the typical appearance of 
newspapers. 25 PILs used a single-column diagram, that is the portrait 
layout (e.g. Clopidogrel, Lisinopril, Simvastin, Losartan Potassium, 
Zofran), the rest were in the landscape format. The division of the columns 
was as follows: 20 had a double-column (e.g. Adenuric,  Buscopan, 
Dulcolax, Omeprazole, Naproxen, Temazepam); 2 had three-columns 
(Alendronic, Benadryl and Benylin); 6 had four-columns (Citalopram, 
Lipitor, Phenergan, Ramipril, Tritace and Warfarin);  2 had five-columns 
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(Avodart and Liquifilm Tears);  1 PIL had  six columns (Coaprovel);  2 had 
a seven- column diagram (Lamictal and Premique); and 1 PIL presented 11 
columns (BuTrans). 
Separation between columns seemed adequate as it ranged from 4 to 6mm, 
and there were margins in all of them. The amount of white space between 
the lines was from 1mm to 4mm according to the font type size. This more 
or less complies with the readability guideline details that recommends to 
keep the line spaces clear and that the space between one line and the next 
should be at least 1.5 times the space between words on a line.  
On the following pages there is an example of a portrait model 
(Hydrocortisone Ointment), and a landscape model (Avodart):  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.4 Portrait model of PIL 
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Fig 4.5 Landscape model of PIL 
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As far as typography is concerned, the MHRA states that: 
“Typography can be defined as designing with type in order to 
communicate a message. The typeface used and other elements 
of graphic design such as colour of text need to be chosen with 
the audience in mind. When used well these aspects organise 
and communicate the information in a way which meets the 
needs of the reader. No matter how well written the text is in 
the PIL if it is set out in a typography which is difficult to read 
it is unlikely that patients will take the time or be encouraged 
to read it”. 
                                           (PIL Guidance 07/12 final p. 6).  
 
The type size varied in the PILs , about 4 had point- type as large as 14 
(Adenuric, Premique, Zoton, Zofran), the others ranged from 9 to 12 , but, 
4 PILs (Atarax, Benadryl, Benylin and Voltarol) presented an 8 point type. 
A font size of 12 point is desirable, however, it is not practical with regard 
to the amount of information that has to be included in a package leaflet. 
Readability is also dependent on the amount and size of paper the patient 
has to handle and especially when he/she needs to unfold and refold the 
PIL for placing it back in the respective packet.  
The readability guideline recommends to use an 8 point font size, for 
the main body of the text and where practical, a larger font size for 
headings, e.g. 12 and 14 points. For visually impaired patients the preferred 
font size should even be between 16 and 20. Italic fonts and underlining are 
not very frequent in the PILs. There is also a minimum use of capital letters 
and this is because the human eye recognizes words in written documents 
by the word shape, so large lower case text is preferred in large blocks of 
text.  
Most of the PILs analysed comply with the guideline as they have 
larger font size than 8. However manufacturers are making the font size 
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slightly bigger bearing in mind the difficulties for certain age groups like 
older patients or those with eyesight problems.  
The information was split up into modules, meaning that the 
information is transferred into relevant questions of the user, thus, 
formulating the information from the perspective of the user. Risk 
information described as procedural information was in longer or shorter 
lists and bullet points according to the seriousness of the disease. For 
example, Propranolol (a beta-blocker for the heart) had 19 bullet points for 
side effects, while Celluvisc eye drops only had 2. None of the PILs had 
repetition of side effects or other information. 
The style in most of the PILs met the National Health Service (NHS) 
guidelines (2007) and the MHRA guidelines (2005, 2012). The sentences 
were not very long (from about 15 to 20 words). Lower-case letters were 
used more where possible. The question and answer format divided the text 
into blocks, quite small blocks, or modules as mentioned before. The bullet 
or numbered points divided up complicated information and began with the 
uncommon and specific case and ended with the common or general case, 
unless this is inappropriate for the product. 
 
Example 
Tell your doctor if you are suffering from 
 pulmonary tuberculosis 
 any allergies that affect your lungs 
 any chronic lung condition. 
 
As required by the Guideline a minimum number of words were used in 
the bullet points and never more than one sentence. There were no more 
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than nine items where the bullet points were simple and no more than five 
when they were complex. Abbreviations were avoided. 
Large bold font was used when emphasizing the text excluding upper case 
letters, italics and underlining. Underlining was not used at all. 
 
4.7.1 The use of pictograms 
Article 62 of Directive 2001/83/EC, as amended, also permits the use of 
images, pictograms and other graphics to improve comprehension except 
for elements of promotional nature. As detailed in the readability guideline 
the use of pictograms, symbols and graphics tends to be misleading and 
confusing due to cultural differences although it is judged as a very helpful 
tool for improving readability of package information leaflets. 
A pictogram is a stylized figurative drawing that is used to convey 
information of an analogical or figurative nature directly to indicate an 
object or to express an idea. Pictograms can fulfill many functions. They 
are used to replace written indications and instructions expressing 
regulatory, mandatory, warning and prohibitory information, when that 
information must be processed quickly (e.g. road traffic signs), when users 
speak different languages (i.e. non-natives), have limited linguistic ability 
(e.g. people with low levels of literacy or little education), or have visual 
problems (e.g. older people), and especially when there is a legal obligation 
to inform, and for the user to comply with, mainly for safety purposes (e.g. 
use of dangerous materials at work). A pictogram needs to capture users' 
attention (users need to see the pictogram), to improve users' 
comprehension of warnings (users need to attend to it), and it also needs to 
increase their awareness of risk, generally by serving as an "instantaneous 
memorandum" of a risk (Otsubo, 1988: 540). 
Chapter 4: Presentation and discussion of results 
 
139 
 
 As reported by Tijus et al., (2005) cited in Schickel, 2007: 90).  there 
are a number of recognized advantages of pictograms in the literature. First 
of all, they have the potential to be interpreted more accurately and more 
quickly than words. Thus, they can serve as “instant reminders” of a hazard 
or an established message. They improve understanding of warnings for 
those with visual or literacy difficulties. They can make warnings more 
noticeable or “attention grabbing”, and they can improve their legibility. 
Pictograms are more easily processed at a distance compared to textual 
information. 
However, there are also a number of disadvantages to relying on 
pictograms. Firstly, the potential for significant confusion (interpreting the 
opposite or often inappropriate meaning), can create an additional safety 
hazard, (Tijus et al., 2005, in Schickel, 2007, 91). Not many pictograms are 
universally understood, hence, they may not be interpreted correctly by all 
groups of consumers and across all cultures. For example a slashed belly of 
a pregnant woman was misinterpreted as avoiding pregnancy as opposed to 
its intended meaning, i.e. “do not use the medicinal product during 
pregnancy” (ibid., 91). Nevertheless, it is deemed that possibilities remain 
to create pictograms and symbols especially with regard to the preparation 
and administration of different dosage forms. One example could be the 
correct demonstration of dissolving a dry powder of an antibiotic 
preparation with water, its storage and its processing immediately prior to 
administration including details on the time intervals for application, as it is 
a medicinal preparation which is widely used especially in paediatric 
populations. 
The same would be easily applicable for displaying certain storage 
conditions with regard to temperature control. Next, it always takes many 
years for any pictogram to reach maximum effectiveness.  
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In order to be adopted, a pictogram must reach a certain level of 
effectiveness, especially when the information to be conveyed concerns 
safety. The method of testing the comprehension and effectiveness of 
pictograms used in ISO 9186 (Public Information Signs) relies on judges 
choosing from a number of response categories: correct understanding of 
the symbol is certain; correct understanding of the symbol is likely; correct 
understanding of the symbol is fairly likely; the meaning conveyed is the 
opposite to that intended; incorrect response given; 'don't know' response 
given; no response given (Tijus et al., 2005 cited in Schickel, 2007: 93). 
Pictograms are quite common in patient information leaflets and are 
intended to provide full and comprehensible information about the 
medicine. A study conducted by Dowse and Ehlers (2005) demonstrated 
that even when instructions were written in a straightforward language, 
there were still unacceptable degree of misunderstanding health care 
professionals and this is made worse when dealing with low-literacy 
patients. So one way of helping these patients is to incorporate visual aids 
such as pictograms.  
They are of benefit to the comprehension and recall of prescription 
instructions, and participants who are given “natural language plus 
pictogram” labels understand information better than participants with only 
“natural language labels” (Dowse and Ehlers, 1998, 2003). In order to 
evaluate the effects of pictograms in patient information leaflets, 
Bernardini and his collaborators (2000) interviewed 1004 patients in 
pharmacies and reported that participants usually read the patient 
information leaflet but they neither understood it easily nor found the 
required information readily. However, most participants (74.3%) 
considered the use of symbols helpful in finding the required information. 
They analyzed to what extent five symbols could be used for each of five 
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topics, and found consistent responses for “side effects”', “pediatric use”, 
“use in pregnancy” and “dosage”, but not for “therapeutic indications” and 
“contraindications”. 
There have, however, also been negative responses to the use of 
pictures because some research has not supported the hypothesis that 
pictograms are beneficial for the acquisition and comprehension of 
information. Such discrepancies may be not related to education, but to 
familiarity and context. Dowse and Ehlers (2003) collected demographic 
data together with information on literacy skills for participants and asked 
them to interpret 46 pictograms. Results showed that there was 
misinterpretation across all educational groups. Another research carried 
out by Knapp, Raynor, Jebar and Price (2005), who examined the effects of 
repeat presentation of pictograms on understandability, found great 
variability in rate of correct interpretation (8 to 90%) and that only three of 
the ten different instruction and warning pictograms were understood by at 
least 85% of the population. After providing their interpretation, 
participants were informed of the correct meaning and then the 
experimental trials were repeated a week later. Results showed that 
participants performed significantly better at the second presentation of 
pictograms. 
According to the European Commission Guideline (1998), symbols and 
pictograms can be used to deliver information provided that the symbol is 
clear and the graphic is understandable. However, pictograms must not be 
used as the only source of communication as seen before, because they may 
convey inadequate details for proper understanding of the medical leaflets 
(Dowse and Ehlers, 2005). The European Commission (1998) also stated 
that pictograms should not replace the actual text, but only be used to assist 
navigation, elucidate or emphasize certain aspects of the text. The health 
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care providers must also give guidance and verbal reinforcement to the 
patients when they are using the medical leaflets (Dowse and Ehlers, 2005). 
Pictograms are especially useful when delivering information such as 
dosing schedule, indication of the drug, side effects, instructions of 
administration and the importance of finishing the medications (Bernardini 
et al., 2000).  
About 8 of the PILs  studied contained pictograms: especially the eye 
drop medications: Celluvisc, Xalatan the inhaler, the thermal patches,  the 
Nurofen PIL for children, (see examples):  
 
Examples  
 
 
 
 
 
 
 
 
 
(Celluvisc eye drops) 
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(Viscotears) 
 
 
The illustrations show the steps to follow in order to use the eye drops 
correctly. We can notice that the text flow is not interrupted by the pictures, 
neither do these surround the images to create confusion. The pictures are 
separated from the verbal text, but at the same time they integrate the words 
as if they were functioning as expert guides, to help the user during the 
process of performing the act of administrating the medicine.  
The next example illustrates medication patches which may be applied 
on various human anatomy parts. The verbal instructions accompany the 
actions depicted, that is, the steps that need to be taken to extract the 
transdermal patch from the sachet and apply it correctly on the skin: 
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(Neupro transdermal patch) 
 
In the example that follows there are two types of instructions: a) how 
to test an inhaler before use, and b) how  to use the inhaler correctly. The 
pictures are not replacing the actual text, but emphasizing certain aspects of 
its verbal parts (see next page). 
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(Ventolin Evohaler) 
 
 
The sketch below is elucidating the user on how to take the capsule out 
of the blister. Perhaps many would give this procedure for granted, but it 
might not be so easy for all users, especially those who encounter visual or 
literacy difficulties. 
 
 
 
 
 
 
 
 
 
 
 (One-Alpha Capsules) 
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The example that follows illustrates the steps necessary for dosing the 
right quantity of medicine with an appropriate syringe, included inside the 
packet: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Nurofen for Children) 
 
 
Very interestingly, several PILs:  Benadryl Plus, Benylin, Istin, Lipitor, 
Paracetamol, Phenergan, Piriton, Tritace and Zovirax included symbols 
such as question marks, exclamation marks, ticks and crosses as visual aids 
beside the sub-headings. These symbols help the reader to grasp the 
message before reading the text or perhaps support the reader who 
encounters reading difficulties. They are very eye catching and give the 
PILs a multimodal nature. Kress and van Leeuwan (2001: 152), describe 
the non-verbal elements “as the visual grammar of multimodal texts”, 
suggesting that “multimodal reading is not of verbal text, but rather 
Chapter 4: Presentation and discussion of results 
 
147 
 
composite reading in which attention jumps back and forth between 
illustrations and text”. All the visual elements are used to make meaning 
more potent. The following are some examples: 
 
Examples  
 
 
 
 
(Paracetomol) 
 
 
 
 
(Zovirax) 
 
 
 
    
(Benylin) 
 
 
 
 
(Piriton) 
 
 
 
(Istin) 
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In the Lipitor and Tritace PILs colourful pictures for warnings are used 
in the contra-indication section ‘Before you take X’. In the following 
symbols, we may notice a glass with a drink and a fruit, that serves to warn 
which drinks and food must be avoided when taking Lipitor. The next 
picture symbolizes a warning for pregnant women, or in case a women is 
trying to become pregnant; the third pictogram is warning breast-feeding 
mothers not to take the medicine.  
 
Examples 
      
 
 
 
 
 
 
 
The Phenergan symbol (below) is a warning for interaction with other 
medicines: 
 
 
 
   (Phenergan) 
 
The pictures on the next page integrate the warnings about driving 
abilities and using other machines, because these abilities can be affected  
whilst taking that medicine: 
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(Lipitor) 
 
 
 
(Tritace) 
 
In the Paracetomol PIL there is also an example of an emoticon beside 
the sub-heading: possible side effects. Taking in consideration the use of 
emoticons, Rezabek and Cochenour (1998) give the following explanation: 
“Emoticons can provide support to written communication, in 
much   the same way that visuals or body language can 
enhance verbal communication. Facial expressions are 
especially important in conveying emotions and nuances of 
meaning during face-to-face interactions, and emoticons are a 
means for better defining emotions and intent regarding a 
particular phrase or statement sent via electronic mail”.  
(Rezabek and Cochenour, 1998: 202) 
 
Although emoticons were initially used to clarify the exact meaning of 
an electronic message, they are now also used in everyday written 
language. In the Paracetomol leaflet the connotation is very clear: ‘be very 
careful and  be informed before taking this medicine or you will have a bad 
time after!’. Not at all smiley, the icon in the example emphasizes a sad 
statement and worrying consequences. 
 
 Example 
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4.8  Summary of findings 
In this research Chapter, 60 PILs (dating from February 2008 to 
February 2012) have been examined from both a discourse and lexico-
grammatical level. The relevant elements of the linguistic theory for the 
assessment of patient information leaflets were identified as generic 
structure and rhetorical functions, specialization of lexis, lexical density, 
status relations. There was concordance between the texts to the extent that 
the PIL was identified as a genre with up to seven structural moves   (e.g. 
introduction to the medicine, account of side effects, dosage, storage). This 
indicates that there seems to be agreement between manufacturers on the 
organization of information within the leaflet, and that they, more or less, 
keep to the recommendations promoted by regulatory organizations. In 
most of the identified moves, more than one rhetorical element is involved, 
thus, suggesting that the reader may be receiving different signals (e.g., 
instruct and inform). 
In a functional text, the objectives of the communication govern what 
takes place at all the other levels in the document, including headings and 
how technical the lexis needs to be. Headings (macro-themes, Martin, 
1992) in a functional text are important because they are signposts by 
which the patient attempts to make sense of the document in response to 
the questions they have (Wright, 1999). When they are inconsistent or 
inappropriate, this hampers the effectiveness of the text, but in the corpus 
they were used appropriately. As for technicality, it needs to be 
acknowledged that patients need to deal with some level of specialised 
language in order to comprehend essential elements of their condition and 
how it might be treated. Most of the PILs did not carry a level of 
technicality that could impede understanding the text. Specialised 
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terminology was, in fact, presented in a way that could be comprehended 
by the user, for example, the explanation given of the technical word in 
brackets. Only few instances in the corpus appeared rather technical from 
the patient’s perspective.  
Readers, whether they believe they know the author of a patient leaflet 
or not, will form an impression of the identity of the writer and his/her 
understanding of the relationship with the writer, from the way the leaflet is 
written. Users may be confused about the authorship, they may be asking 
whether the sender of the message knows the individual situation or not. 
Patients may comprehend what they read, but they can also decide that the 
information received, does not apply to them (Wright, 1999). This is where 
relations established between doctor/expert and patient/lay user, by way of 
the text are crucial. This role relationship was quite consistent in the PILs 
investigated, for example, the use of the second person pronoun to address 
the patient directly and make him/her an active “participant” in the 
“process” (Halliday, 1994) of ‘taking the medicine’.  
There was variability in text length because some were longer than 
others, especially the PILs that dealt with more serious illnesses. Bullets 
and numbering were used in most of the leaflets. Bullets served for the 
listing of items where the order and relations between them were not 
important, and numbering for the listing of items where the order was 
important, or when a taxonomy actually existed (e.g. giving instructions for 
using a medication). 
The information contained in the leaflets was not found to be densely 
packed. The lexis used in the majority of the PILs can be identified as  
being far from the ‘spoken-like’ end as estimated by Halliday, (1985). 
Analyses of lexical density, carried out on one section of the leaflet, 
demonstrated that the average number of density items was from 5 to 7 in 
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shorter texts, and from 7 to 9 in longer texts. This might sound as being 
more academic in theory, but in practice, the PILs are nearer to user-
friendliness in style, in order to meet patients’ needs.    
Design issues (Hartley, 1994; 1999) such as layout, font size and style, 
and use of visual material may also have an impact upon patients’ capacity 
to comprehend information leaflets. The results showed that a few PILs had 
a font type as large as 14,  a few, a font size as small as 8, and the rest 
ranged from 10 to 12 (12 font type is recommended by the regulating 
authorities). Considering the MHRA’s guidelines as regard to layout, also 
columns, spacing, and the use of colour were taken account of for the 
analyses. As for visual material, about 20% of the corpus included 
photographs, pictograms, symbols and other illustrations, thus, conveying a 
multimodal nature (Kress and van Leeuwan, 2001) to the leaflets.  
4.9  Conclusion 
In conclusion, the patient information leaflets in this corpus were 
characterised by low variability in generic structure, and by quite a 
standard set of rhetorical elements within and between the generic moves. 
As a sub-genre instance of medical texts, they have shown to carry a 
number of conventional indicators. The overall communicative purpose is 
to inform the reader about a therapeutic medication. 
In answer to the research questions: what are the features in PILs to 
contribute to the fulfilment of writer and reader objectives? Is there a 
standard/conventional text structure in PILs? And, is patient  centeredness 
manifested linguistically? Findings show that almost all the PILs analysed 
followed a standard text structure of seven moves. They displayed 
numerous examples of plain language features which accentuate a patient-
centred, user-friendly approach, therefore, contributing to the role 
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relationship between health professionals and lay patients. However, as 
noticed throughout the analysis, there were also some examples of the use 
of traditional expert language, and some aspects of layout print, which act 
to the detriment of user-friendliness in patient communication. In sum, 
about 70% of the PILs could be said to constitute a best-practice example; 
20%, a mixture of positive and negative features. 10% was still quite far 
from constituting communicative best practice both from a linguistic and 
layout point of view. It is also true, however, that several leaflets included 
examples of very colloquial language to a degree that had never been seen 
in patient information leaflets before. 
Since its authoritative introduction, the statutory PIL has been a subject 
of study and improvement. However, there is still ample room for further 
improvement. The reason being is that the patient information leaflet is a 
very challenging genre with its many legal requirements, and with a target 
group which potentially consists of the entire population of a country. It 
plays a significant role in the patient empowerment process and the 
improvements to the genre witnessed over the past years deserve to be 
highlighted, while it is still important to point out any shortcomings to 
ensure continuous development. 
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CHAPTER FIVE 
 
LABELS 
 
 
5.1 New Labels on medicine packets and bottles 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PILs are the leaflets (folded in a sort of Z shape) produced by the 
manufacturers and placed inside medicine packets, both prescribed (P) and 
OTC medications. Labels, on the other hand, are the printed texts added, 
actually stuck, on medicine packets and bottles by the pharmacist (as 
already mentioned). The label on the medicine repeats the instructions on 
the prescription the doctor wrote out for the patient. When the pharmacist 
dispenses the medicine, he/she will stick the label on the medicine 
container or its packaging, and every label is tailored to each patient’s case. 
The information on the medicine’s dispensing label usually includes: 
 the name of the patient; 
 the name and address of the pharmacy that dispensed the medicine; 
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 the date the medicine is dispensed; 
 the name of the medicine;  
 the dose the patient should take, how to take it and how often;  
 the total quantity of medicine in the container and the medicine 
strength; 
 if necessary, any cautions or warning messages that apply to the 
medicine are added. 
a) The medicine’s name 
The medicine may have two names: 
 the brand name (manufacturer’s name);  
 the generic name for the active ingredient in the medicine scientific 
name). For example Pantoprazole is the active ingredient found in 
tablets to protect the stomach from producing too much acid. 
If the prescription shows the medicine’s brand name, the label should show 
both the brand name and the generic name. 
b) The dose 
The label on the  prescribed medicine will repeat the dosage instructions 
from the prescription. This says how to take or use the medicine, for 
example: 
 take one tablet four times a day; 
 take one 5ml spoonful four times a day. 
c) Extra instructions 
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The pharmacist may also include other instructions on the medicine label. 
Some examples are:  
 shake the bottle  
 store in a cool place  
 discard, for example, 28 days after opening  
 do not use after a certain date  
d) Cautions and warning messages 
It’s a legal requirement that the dispensing label for all dispensed 
medicines should say ‘Keep out of the reach of children’. All liquid 
medicines for external use, for example a cream to go on the skin, 
should also say ‘For external use only’. 
Depending on the type of medicine, cautions or warning messages may 
be added on a separate label. There are recommended wordings for these 
cautions, some of which were changed in 2011 (see next paragraph).  
The labels should also have the following features:  
 Words typed in easy-to-read 12-point type, with the patient's 
name, drug name, and drug instructions in the largest letters. 
But not all pharmacies follow this suggestion.  
 Warnings typed directly onto patient labels in a large typeface. 
Research has found that fewer than 10 percent of people examine 
their drug containers for the colorful warning stickers that sometimes 
appear on the bottle. And warnings that appear on the labels that are 
typed in very small type can be hard to read or hard to find.  
 The generic and brand name of a drug. This might prevent 
someone from mistakenly taking a double dose of the same 
Chapter 5: Labels 
 
157 
 
medication prescribed by two doctors and filled at two different 
pharmacies, one as the generic version and one as the brand-name 
drug. In fact patients should be advised to fill all of their 
prescriptions at the same pharmacy to help them avoid accidental 
mix-ups like the above stated.  
 Images or physical descriptions of the pills in the container. 
Someone who reads that he or she should be taking round blue 
tablets will probably call the pharmacy if there are oval-shaped white 
pills in the container.  
 No extra zeroes (like 5.0 mg), so patients who take 5 mg of a 
medication don't incorrectly remember it as "50 mg" when talking to 
a doctor.  
 The pharmacy's information—name, address, and phone 
number—at the bottom of the label, so the patient's medicine 
information is prominently displayed at the top for easy reading, (see 
appendix for examples). 
5.2     New wordings on medicine labels 
Wordings on the labels had not been changed since 1985. The words of 
the original cautionary advisory labels was recommended by a working 
party of the Royal Pharmaceutical Society of Great Britain and since 1985 
had been included in the British National Formulary (BNF), the 
authoritative textbook that pharmacists, doctors and nurses, and other 
health professionals use for looking up information about prescription and 
non-prescription medicine. The BNF is published by the Royal 
Pharmaceutical Society and the British Medical Association, under the 
authority of a Joint Formulary Committee made up of representatives from 
these bodies and the Department of Health. 
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But last March 2011, the BNF brought some important changes 
following the work by a group of researchers at the University of Leeds, in 
collaboration with Leeds-based company 
 
Luto Research. The researches 
revealed that many commonly-used phrases on medicine labels were easily 
misunderstood by many people.  
On Thursday 3 March 2011 an interview on BBC Radio 4
5
 was 
released called: Clear English coming to your medicine cabinet. 
The expert interviewed was Professor of Pharmacy Theo Raynor of 
Luto and University of Leeds (see transcript, 5.4). 
Professor Raynor argued that there were confusing instructions on 
medicine bottles and packets of pills dispensed from the UK pharmacies 
and that it was necessary to replace those with simpler words and phrases 
in order to help people understand them better. 
Around two million prescriptions are issued every day in the UK, and 
every medicine must have a printed label that gives details on how to take 
the medicine. However, the Leeds research results showed that some of the 
standard phrases that were printed on the labels were confusing and caused 
some  patients to behave in ways that would compromise the safety and 
effectiveness of their treatment. Researchers gathered that the switch to 
clearer language would help make sure that patients would take their 
medicines as they should do.  
“It is vital that wordings on labels are simple and straightforward”, said 
Professor Raynor. “Most medicines do contain leaflets providing detailed 
information for patients, but these leaflets can get lost or overlooked. 
Patients’ behaviour tends to be guided by the instructions on the outside of 
medicine bottles and packets of pills, so these must be as clear and 
unambiguous as possible.” (Raynor, BBC Radio 4, 2011). 
                                                 
5
 BBC Radio 4 Today Programme: Interview with John Humphries, 3 March 2011 
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The research carried out by Professor Raynor and Dr Peter Knapp 
(from the University of Leeds, School of Healthcare) and David Bryant 
(General Manager, Luto Research),  consisted in testing a selection of 
instructions on a large number of volunteers from the general public. 
Participants were all literate in English and covered a range of ages 20-80,  
and had educational abilities. They were asked to read and answer 
questions about medicines with several label wordings and medicines with 
single-label wordings. A group of paediatric medicines was also created 
and used for participants who were parents or carers of children. The 
questions were agreed by an expert panel consisting of pharmacists from 
Luto Research and the BNF. Almost 200 lay participants were involved 
over three rounds of testing. The results from each round of testing were 
combined with good practice and research evidence to produce revised 
wordings that reflect current best practice
3
 in written medicine information 
for patients. In other words, if any of the phrases were found confusing by 
the volunteers, the researchers  rewrote them  by using best practice in clear 
English, and then tested them again with another group of volunteers. Of 
the 32 labels, three existing wordings  -labels 12, 17, and 29-  (see 
paragraph 4.3) worked well and are retained in the proposed revised 
wordings for the new labels. Although the wording of individual labels 
may have changed, the intended instruction of each of the numbered labels 
remains the same. 
The proposed changes include a terminology that is better understood 
by patients and not misleading. For example, user testing showed that, in 
label 1, the word “drowsiness” is not always readily understood and has 
been improved by using the wording “This medicine may make you  
sleepy”. The recommended changes (see section 5.3), following user 
testing, also produce more precise instructions, which present little 
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opportunity for different interpretations. Thus, in label 4, the wording 
“Avoid alcoholic drink”,  is replaced with “Do not drink alcohol while 
taking this medicine”. Dr Raynor said, in fact, that the word “Avoid” to 
some people meant that they should only limit their alcohol intake. Hence 
“Do not “ conveys a simpler command. (Raynor, BBC Radio 4, 2011). 
Luto’s testing showed that label wordings that can be incorporated in an 
appropriate position in the directions for dosage or administration (labels 
21 to 28) did not generally work well. Separating these wordings into a 
discrete instruction worked better and this format was adopted in the 
proposed wordings.  
The  revised phrases were included in the last version of the BNF (BNF 
61, March 2011), and Duncan Enright, Publishing Director at BNF 
Publications said: “It has never been easier to change labels on medicines 
given current computerised systems and therefore we hope that the large 
pharmacy chains and independent pharmacies will adopt these 
recommendations”, (March 2011). 
The new software version has been downloaded  by the  pharmacies 
and currently  the new instruction  labels are printed. 
 
 
 
 
 
 
 
 
 
Chapter 5: Labels 
 
161 
 
5.3 BNF cautionary and advisory labels: Before and after 
recommended changes 
 
On the label 
 
Before:   wording of original cautionary and advisory labels 
 
1 Warning: May cause drowsiness 
 
2 Warning: May cause drowsiness. If affected do not drive or  
operate machinery. 
 
4 Warning. Avoid alcoholic drink 
 
5 Do not take indigestion remedies at the same time of day as 
this medicine 
 
7 Do not take milk, indigestion remedies, or medicines 
containing iron or zinc at the same time of day as this medicine 
 
8 Do not stop taking this medicine except on your doctor’s 
advice 
 
9 Take at regular intervals. Complete the prescribed course 
unless otherwise directed 
 
10 Warning. Follow the printed instructions you have been given 
with this medicine 
 
11 Avoid exposure of skin to direct sunlight or sun lamps 
 
14 This medicine may colour the urine 
 
15 Caution flammable: keep away from fire or flames 
 
16 Allow to dissolve under the tongue. Do not transfer from this 
container. Keep tightly closed. Discard eight weeks 
after opening 
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19 Warning. Causes drowsiness which may continue the next day. 
If affected do not drive or operate machinery. Avoid alcoholic 
drink 
 
21 . . . with or after food 
 
22 . . . half to one hour before food 
 
23 . . . an hour before food or on an empty stomach 
 
25 . . . swallowed whole, not chewed 
 
27 . . . with plenty of water 
 
28 To be spread thinly … 
 
30 Do not take with any other Paracetamol products 
 
32 Contains aspirin 
 
 
After:  wording of revised cautionary and advisory labels  
 (BNF 61) 
 
1 Warning: This medicine may make you sleepy 
 
2 Warning: This medicine may make you sleepy . If 
this happens, do not drive or use tools or machines. Do not 
drink alcohol 
 
4 Warning: Do not drink alcohol while taking this medicine 
 
5 Do not take indigestion remedies 2 hours before or after you 
take this medicine 
 
7 Do not take milk, indigestion remedies, or medicines 
containing iron or zinc, 2 hours before or after you take this 
medicine 
 
8 Warning: Do not stop taking this medicine unless your doctor 
tells you to stop 
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9 Space the doses evenly throughout the day. Keep taking this 
medicine until the course is finished, unless you are told to 
stop 
 
10 Warning: Read the additional information given with this 
medicine 
 
11 Protect your skin from sunlight — even on a bright but cloudy 
day. Do not use sunbeds 
 
12 This medicine may colour your urine. This is harmless 
 
15 Caution: flammable. Keep your body away from 
fire or flames after you have put on the medicine 
 
16 Dissolve the tablet under your tongue—do not swallow. Store 
the tablets in this bottle with the cap tightly closed. Get a new 
supply 8 weeks after opening 
 
19 Warning: This medicine makes you sleepy. If you still feel 
sleepy the next day, do not drive or use tools or machines. Do 
not drink alcohol 
 
21 Take with or just after food, or a meal 
 
22 Take 30 to 60 minutes before food 
 
23 Take this medicine when your stomach is empty. This means 
an hour before food or 2 hours after food 
 
25 Swallow this medicine whole. Do not chew or break 
 
27 Take with a full glass of water 
 
28 Spread thinly on the affected skin only 
 
30 Contains Paracetamol. Do not take anything else containing 
Paracetamol while taking this medicine 
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32 Contains aspirin. Do not take anything else containing aspirin 
while taking this medicine 
 
5.4 Transcript 
 
Clear English coming to your medicine cabinet by Theo Raynor 
 
Location:  BBC Radio 4 Today Programme:  Interview with John 
Humphries 
    
University of Leeds press release 
Thursday 3 March 2011 
 
The interview may be downloaded at: 
http://leeds.academia.edu/TheoRaynor/Talks/37030/Clear_English_coming
_to_your_cabinet...  
 
 
Interviewer: Pharmacists are getting worried about the 
instructions stuck on the medicines prescribed by GPs. 
Apparently an awful lot of us don’t understand them and that 
can be dangerous. Theo Raynor is professor of Pharmacy 
Practice at  Leed’s University who led a research into this. 
 
Interviewer: Good morning Theo! 
Prof. Theo: Good morning! 
 
Int: How misleading,  in what sense? 
Prof. Theo: Well, there are about 30 labels that pharmacies 
routinely use on medicines, things like ‘Avoid alcohol whether 
before or after food’, ‘Take at regular intervals’, and we found in 
our research that many of these things even if they look simple, 
people didn’t understand them very well. We worked with 
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nearly 200 people of the public to test the labels and that’s 
where we found that they can be misunderstood. So we used 
the clinical expertise of the  British National Formulary and our 
research expertise of the University of Leeds, and we used a 
testing user research at Luto Research, and came up with what 
we have found to be much more straightforward and clearer 
labels. 
 
Int: Right, so this has nothing to do with the GP, then? 
Prof. Theo: No, the pharmacists are required to put additional 
labels when they dispense medicines, so we now come up with 
a new set of labels which they will now routinely use for all the 
prescriptions that are written by GPs. 
 
Int: So, effectively, it’s a different kind of language, obviously, 
you’re not changing the way we take things, like particular 
drugs, it’s just the use of language? 
Prof. Theo:  Absolutely! Let me give you an example: we’ve 
previously used the wording ‘Avoid alcoholic drink’, and we 
found that people interpreted that in a number of different 
ways, but what we mean is ‘Do not drink alcohol while taking 
this medicine’. So it’s just simply setting things in ways that 
people can understand. 
 
Int: I wonder why people couldn’t understand ‘avoid alcohol’. 
What did they think about it then? 
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Prof. Theo: Well, some people thought it meant ‘you should 
try.., well, if you drink alcohol, try and see if it affects you before 
you drive, for instance, and so on. It does give the opportunity 
to give various interpretations, so ‘avoid’ isn’t very specific. 
 
Int: Oh, right! Anything else like that sort of thing? 
Prof. Theo: Oh, well, yes. Many medicines either won’t work or 
you’ll have more side effects if you don’t have food in your 
stomach when you take them. And we used to put on the labels 
‘with or without food’, and again, even that is a little bit vague, 
so we are now going to say: ‘Take with or just after food, or a 
meal’. So, we’re just thinking about things from the medicine’s 
taker perspective and write in a way that they can relate it to 
their daily lives. 
 
Int: And it really matters, does it? Because I suppose an awful 
lot of us think when they actually say ‘Take with a meal’, they 
don’t actually really mean before, after or during. 
 
Prof. Theo:   It matters very much. If you think of medicines like 
Ibuprofen if you don’t take them on a full stomach, then they 
can cause quite serious upsets and stomach ulcers. So, yes, it 
matters very much in many cases. 
 
Int:  Well, thanks very much Professor Theo.  
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The picture below shows Professor Theo Raynor with examples of 
medicine packets and bottles including the new wordings on the labels. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Fig. 5.1 Picture of Professor Raynor 
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